<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en">
    
    <head><meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
        <!-- AppResources meta begin -->
        <meta name="paf-app-resources" content="" />
                 <script type="text/javascript">var ncbi_startTime = new Date();</script>
            
        <!-- AppResources meta end -->
        
        <!-- TemplateResources meta begin -->
        <meta name="paf_template" content="" />

        <!-- TemplateResources meta end -->
        
        <!-- Logger begin -->
        <meta name="ncbi_db" content="books" /><meta name="ncbi_pdid" content="book-part" /><meta name="ncbi_acc" content="NBK1198" /><meta name="ncbi_domain" content="gene" /><meta name="ncbi_report" content="record" /><meta name="ncbi_type" content="fulltext" /><meta name="ncbi_objectid" content="" /><meta name="ncbi_pcid" content="/NBK1198/" /><meta name="ncbi_pagename" content="Phelan-McDermid Syndrome - GeneReviews® - NCBI Bookshelf" /><meta name="ncbi_bookparttype" content="chapter" /><meta name="ncbi_app" content="bookshelf" />
        <!-- Logger end -->
        
        <title>Phelan-McDermid Syndrome - GeneReviews® - NCBI Bookshelf</title>
        
        <!-- AppResources external_resources begin -->
        <link rel="stylesheet" href="/core/jig/1.14.8/css/jig.min.css" /><script type="text/javascript" src="/core/jig/1.14.8/js/jig.min.js"></script>

        <!-- AppResources external_resources end -->
        
        <!-- Page meta begin -->
        <meta name="robots" content="INDEX,FOLLOW,NOARCHIVE" /><meta name="citation_inbook_title" content="GeneReviews® [Internet]" /><meta name="citation_title" content="Phelan-McDermid Syndrome" /><meta name="citation_publisher" content="University of Washington, Seattle" /><meta name="citation_date" content="2018/06/07" /><meta name="citation_author" content="Katy Phelan" /><meta name="citation_author" content="R Curtis Rogers" /><meta name="citation_author" content="Luigi Boccuto" /><meta name="citation_pmid" content="20301377" /><meta name="citation_fulltext_html_url" content="https://www.ncbi.nlm.nih.gov/books/NBK1198/" /><meta name="citation_keywords" content="22q13.3 Deletion Syndrome" /><meta name="citation_keywords" content="Chromosome 22q13.3 Deletion Syndrome" /><meta name="citation_keywords" content="Deletion 22q13 Syndrome" /><meta name="citation_keywords" content="22q13.3 Deletion Syndrome" /><meta name="citation_keywords" content="Chromosome 22q13.3 Deletion Syndrome" /><meta name="citation_keywords" content="Deletion 22q13 Syndrome" /><meta name="citation_keywords" content="SH3 and multiple ankyrin repeat domains protein 3" /><meta name="citation_keywords" content="SHANK3" /><meta name="citation_keywords" content="Phelan-McDermid Syndrome" /><link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /><meta name="DC.Title" content="Phelan-McDermid Syndrome" /><meta name="DC.Type" content="Text" /><meta name="DC.Publisher" content="University of Washington, Seattle" /><meta name="DC.Contributor" content="Katy Phelan" /><meta name="DC.Contributor" content="R Curtis Rogers" /><meta name="DC.Contributor" content="Luigi Boccuto" /><meta name="DC.Date" content="2018/06/07" /><meta name="DC.Identifier" content="https://www.ncbi.nlm.nih.gov/books/NBK1198/" /><meta name="description" content="Phelan-McDermid syndrome is characterized by neonatal hypotonia, absent to severely delayed speech, developmental delay, and minor dysmorphic facial features. Most affected individuals have moderate to profound intellectual disability. Other features include large fleshy hands, dysplastic toenails, and decreased perspiration that results in a tendency to overheat. Normal stature and normal head size distinguishes Phelan-McDermid syndrome from other autosomal chromosome disorders. Behavior characteristics include mouthing or chewing non-food items, decreased perception of pain, and autism spectrum disorder or autistic-like affect and behavior." /><meta name="og:title" content="Phelan-McDermid Syndrome" /><meta name="og:type" content="book" /><meta name="og:description" content="Phelan-McDermid syndrome is characterized by neonatal hypotonia, absent to severely delayed speech, developmental delay, and minor dysmorphic facial features. Most affected individuals have moderate to profound intellectual disability. Other features include large fleshy hands, dysplastic toenails, and decreased perspiration that results in a tendency to overheat. Normal stature and normal head size distinguishes Phelan-McDermid syndrome from other autosomal chromosome disorders. Behavior characteristics include mouthing or chewing non-food items, decreased perception of pain, and autism spectrum disorder or autistic-like affect and behavior." /><meta name="og:url" content="https://www.ncbi.nlm.nih.gov/books/NBK1198/" /><meta name="og:site_name" content="NCBI Bookshelf" /><meta name="og:image" content="https://www.ncbi.nlm.nih.gov/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-gene-lrg.png" /><meta name="twitter:card" content="summary" /><meta name="twitter:site" content="@ncbibooks" /><meta name="bk-non-canon-loc" content="/books/n/gene/gr_22q13_3/" /><link rel="canonical" href="https://www.ncbi.nlm.nih.gov/books/NBK1198/" /><link rel="stylesheet" href="/corehtml/pmc/css/figpopup.css" type="text/css" media="screen" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.22/css/books.min.css" type="text/css" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.22/css/books_print.min.css" type="text/css" media="print" /><style type="text/css">p a.figpopup{display:inline !important} .bk_tt {font-family: monospace}  .first-line-outdent .bk_ref {display: inline}  .body-content h2, .body-content .h2  {border-bottom: 1px solid #97B0C8} .body-content h2.inline {border-bottom: none} a.page-toc-label , .jig-ncbismoothscroll a {text-decoration:none;border:0 !important} .temp-labeled-list  .graphic {display:inline-block !important} .temp-labeled-list  img{width:100%}</style><script type="text/javascript" src="/corehtml/pmc/js/jquery.hoverIntent.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/common.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/large-obj-scrollbars.min.js"> </script><script type="text/javascript">window.name="mainwindow";</script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.22/book-toc.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.22/books.min.js"> </script><meta name="book-collection" content="NONE" />

        <!-- Page meta end -->
    <link rel="shortcut icon" href="//www.ncbi.nlm.nih.gov/favicon.ico" /><meta name="ncbi_phid" content="CE89E932E041937100000000084003A8.m_12" />
<meta name='referrer' content='origin-when-cross-origin'/><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/css/3852956/3985586/3808861/4121862/3974050/3917732/251717/4098876/14534/45193/4113719/3849091/3984811/3751656/4033350/3840896/3577051/3852958/4008682/3881636/3579733/4062871/12930/3964959/3854974/36029/4128070/9685/3549676/3609192/3609193/3609213/3395586.css" /><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/css/3411343/3882866.css" media="print" /></head>
    <body class="book-part">
        <div class="grid">
            <div class="col twelve_col nomargin shadow">
                <!-- System messages like service outage or JS required; this is handled by the TemplateResources portlet -->
                <div class="sysmessages">
                    <noscript>
	<p class="nojs">
	<strong>Warning:</strong>
	The NCBI web site requires JavaScript to function. 
	<a href="/guide/browsers/#enablejs" title="Learn how to enable JavaScript" target="_blank">more...</a>
	</p>
	</noscript>
                </div>
                <!--/.sysmessage-->
                <div class="wrap">
                    <div class="page">
                        <div class="top">
                            <div class="universal_header" id="universal_header"><ul class="inline_list jig-ncbimenu ui-ncbimenu resources_list" id="navcontent"><li class="ui-ncbimenu-item-leaf ui-ncbimenu-item-first ui-helper-reset ui-ncbimenu-item-no-hlt"><a class="ui-ncbimenu-link-first" href="/" role="banner" title="NCBI Home" id="ncbihome" accesskey="1"><span class="offscreen_noflow">NCBI</span><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/img/28977" class="ncbi_logo" title="NCBI" alt="NCBI Logo" /></a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#maincontent" title="Skip to the content" tabindex="0" accesskey="3">Skip to main
                        content</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#navcontent" title="Skip to the navigation" tabindex="0" accesskey="4">Skip to
                        navigation</a></li><li id="resource-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first ui-helper-reset"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#resources">Resources</a></li><li id="all-howtos-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#howto">How To</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="/guide/browsers/#accesskeys" title="About My NCBI Accesskeys" tabindex="0" accesskey="0">About NCBI Accesskeys</a></li></ul><div class="myncbi"><span id="myncbiusername" style="display:none"><a href="/account/settings/" id="mnu" title="Edit account settings"></a></span><a accesskey="2" href="/myncbi/" id="myncbi" style="display:none">My NCBI</a><a href="/account/" id="sign_in">Sign in to NCBI</a><a href="/account/signout/" id="sign_out" style="display:none">Sign Out</a></div></div>
                            <div class="header">
    <div class="res_logo"><h1 class="res_name"><a href="/books/" title="Bookshelf home">Bookshelf</a></h1><h2 class="res_tagline"></h2></div>
    <div class="search"><form method="get" action="/books/"><div class="search_form"><label for="database" class="offscreen_noflow">Search database</label><select id="database"><optgroup label="Recent"><option value="books" selected="selected" class="last" data-ac_dict="bookshelf-search">Books</option></optgroup><optgroup label="All"><option value="gquery">All Databases</option><option value="assembly">Assembly</option><option value="biocollections">Biocollections</option><option value="bioproject">BioProject</option><option value="biosample">BioSample</option><option value="biosystems">BioSystems</option><option value="books" data-ac_dict="bookshelf-search">Books</option><option value="clinvar">ClinVar</option><option value="cdd">Conserved Domains</option><option value="gap">dbGaP</option><option value="dbvar">dbVar</option><option value="gene">Gene</option><option value="genome">Genome</option><option value="gds">GEO DataSets</option><option value="geoprofiles">GEO Profiles</option><option value="gtr">GTR</option><option value="homologene">HomoloGene</option><option value="ipg">Identical Protein Groups</option><option value="medgen">MedGen</option><option value="mesh">MeSH</option><option value="ncbisearch">NCBI Web Site</option><option value="nlmcatalog">NLM Catalog</option><option value="nuccore">Nucleotide</option><option value="omim">OMIM</option><option value="pmc">PMC</option><option value="popset">PopSet</option><option value="probe">Probe</option><option value="protein">Protein</option><option value="proteinclusters">Protein Clusters</option><option value="pcassay">PubChem BioAssay</option><option value="pccompound">PubChem Compound</option><option value="pcsubstance">PubChem Substance</option><option value="pubmed">PubMed</option><option value="snp">SNP</option><option value="sparcle">Sparcle</option><option value="sra">SRA</option><option value="structure">Structure</option><option value="taxonomy">Taxonomy</option><option value="toolkit">ToolKit</option><option value="toolkitall">ToolKitAll</option><option value="toolkitbookgh">ToolKitBookgh</option></optgroup></select><div class="nowrap"><label for="term" class="offscreen_noflow" accesskey="/">Search term</label><div class="nowrap"><input type="text" name="term" id="term" title="Search Books. Use up and down arrows to choose an item from the autocomplete." value="" class="jig-ncbiclearbutton jig-ncbiautocomplete" data-jigconfig="dictionary:'bookshelf-search',disableUrl:'NcbiSearchBarAutoComplCtrl'" autocomplete="off" data-sbconfig="ds:'no',pjs:'no',afs:'no'" /></div><button id="search" type="submit" class="button_search nowrap" cmd="go">Search</button></div></div></form><ul class="searchlinks inline_list"><li>
                        <a href="/books/browse/">Browse Titles</a>
                    </li><li>
                        <a href="/books/advanced/">Advanced</a>
                    </li><li class="help">
                        <a href="/books/NBK3833/">Help</a>
                    </li></ul></div>
</div>

                            
                            
                        <!--<component id="Page" label="headcontent"/>-->
                            
                        </div>
                        <div class="content">
                            <!-- site messages -->
                            <!-- Custom content 1 -->
<div class="col1">
    
</div>

<div class="container">
    <div id="maincontent" class="content eight_col col">
        <!-- Custom content in the left column above book nav -->
        <div class="col2">
            
        </div>
        
        <!-- Book content -->
        

        <!-- Custom content between navigation and content -->
        <div class="col3">
            
        </div>
        
        <div class="document">
            <div class="pre-content"><div><div class="bk_prnt"><p class="small">NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.</p><p>Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2019. </p></div><div class="iconblock clearfix whole_rhythm no_top_margin bk_noprnt"><a class="img_link icnblk_img" title="All GeneReviews" href="/books/n/gene/"><img class="source-thumb" src="/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-gene-lrg.png" alt="Cover of GeneReviews®" height="100px" width="80px" /></a><div class="icnblk_cntnt eight_col"><h2>GeneReviews<sup>®</sup> [Internet].</h2><a data-jig="ncbitoggler" href="#__NBK1198_dtls__">Show details</a><div style="display:none" class="ui-widget" id="__NBK1198_dtls__"><div>Adam MP, Ardinger HH, Pagon RA, et al., editors.</div><div>Seattle (WA): <a href="http://www.washington.edu" ref="pagearea=page-banner&amp;targetsite=external&amp;targetcat=link&amp;targettype=publisher">University of Washington, Seattle</a>; 1993-2019.</div></div><div class="half_rhythm"><ul class="inline_list"><li style="margin-right:1em"><a class="bk_cntns" href="/books/n/gene/">GeneReviews by Title</a></li></ul></div><div class="bk_noprnt"><form method="get" action="/books/n/gene/" id="bk_srch"><div class="bk_search"><label for="bk_term" class="offscreen_noflow">Search term</label><input type="text" title="Search GeneReviews" id="bk_term" name="term" value="" data-jig="ncbiclearbutton" /> <input type="submit" class="jig-ncbibutton" value="Search GeneReviews" submit="false" style="padding: 0.1em 0.4em;" /></div></form><div><ul class="inline_list"><li><a href="/books/n/gene/advanced/">GeneReviews Advanced Search</a></li><li style="margin-left:.5em"><a href="/books/n/gene/helpadvsearch/">Help</a></li></ul></div></div></div><div class="icnblk_cntnt two_col"><div class="pagination bk_noprnt"><a class="active page_link prev" href="/books/n/gene/pjs/" title="Previous page in this title">&lt; Prev</a><a class="active page_link next" href="/books/n/gene/pku/" title="Next page in this title">Next &gt;</a></div></div></div></div></div>
            <div class="main-content lit-style" itemscope="itemscope" itemtype="http://schema.org/CreativeWork"><div class="meta-content fm-sec"><h1 id="_NBK1198_"><span class="title" itemprop="name">Phelan-McDermid Syndrome</span></h1><div itemprop="alternativeHeadline" class="subtitle whole_rhythm">Synonyms: 22q13.3 Deletion Syndrome, Chromosome 22q13.3 Deletion Syndrome, Deletion 22q13 Syndrome</div><p class="contrib-group"><span itemprop="author">Katy Phelan</span>, PhD, FACMG, <span itemprop="author">R Curtis Rogers</span>, MD, FACMG, and <span itemprop="author">Luigi Boccuto</span>, MD.</p><a data-jig="ncbitoggler" href="#__NBK1198_ai__" style="border:0;text-decoration:none">Author Information</a><div style="display:none" class="ui-widget" id="__NBK1198_ai__"><div class="contrib half_rhythm"><span itemprop="author">Katy Phelan</span>, PhD, FACMG<div class="affiliation small">Director of Cytogenetics<br />Florida Cancer Specialists &#x00026; Research Institute<br />Fort Myers, Florida<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="moc.recnaclf@nalehpk" class="oemail">moc.recnaclf@nalehpk</a></div></div></div><div class="contrib half_rhythm"><span itemprop="author">R Curtis Rogers</span>, MD, FACMG<div class="affiliation small">Senior Clinical Geneticist<br />Greenwood Genetic Center<br />Greenwood, South Carolina<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="gro.cgg@sregorc" class="oemail">gro.cgg@sregorc</a></div></div></div><div class="contrib half_rhythm"><span itemprop="author">Luigi Boccuto</span>, MD<div class="affiliation small">Research Scientist<br />JC Self Research Institute<br />Greenwood Genetic Center<br />Greenwood, South Carolina<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="gro.cgg@otuccobl" class="oemail">gro.cgg@otuccobl</a></div></div></div></div><p class="small">Initial Posting: <span itemprop="datePublished">May 11, 2005</span>; Last Update: <span itemprop="dateModified">June 7, 2018</span>.</p><p><em>Estimated reading time: 36 minutes</em></p></div><div class="jig-ncbiinpagenav body-content whole_rhythm" data-jigconfig="allHeadingLevels: ['h2'],smoothScroll: false" itemprop="text"><div id="gr_22q13_3.Summary" itemprop="description"><h2 id="_gr_22q13_3_Summary_">Summary</h2><div><h4 class="inline">Clinical characteristics.</h4><p>Phelan-McDermid syndrome is characterized by neonatal hypotonia, absent to severely delayed speech, developmental delay, and minor <a class="def" href="/books/n/gene/glossary/def-item/dysmorphic/">dysmorphic</a> facial features. Most <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals have moderate to profound intellectual disability. Other features include large fleshy hands, dysplastic toenails, and decreased perspiration that results in a tendency to overheat. Normal stature and normal head size distinguishes Phelan-McDermid syndrome from other <a class="def" href="/books/n/gene/glossary/def-item/autosomal/">autosomal</a> <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> disorders. Behavior characteristics include mouthing or chewing non-food items, decreased perception of pain, and autism spectrum disorder or autistic-like affect and behavior.</p></div><div><h4 class="inline">Diagnosis/testing.</h4><p>The diagnosis of Phelan-McDermid syndrome is established in a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> with typical clinical findings and detection of a <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a> of <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> 22q13.3 with involvement of at least part of <i>SHANK3</i>, or a heterozygous <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in <i>SHANK3</i> on <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a>. Individuals diagnosed by <a class="def" href="/books/n/gene/glossary/def-item/chromosomal-microarray/">chromosomal microarray</a> should have a <a class="def" href="/books/n/gene/glossary/def-item/karyotype/">karyotype</a> to evaluate for the presence of a ring chromosome 22.</p></div><div><h4 class="inline">Management.</h4><p><i>Treatment of manifestations:</i> Early referral for developmental support / special education; assistive technology for communication, oral-motor therapy to alleviate chewing and swallowing problems; standard treatment of seizures, hearing loss, recurrent ear infection, visual problems, and other identified medical needs. Regular professional dental hygiene, routine brushing, and fluoride treatment are important as enamel may be damaged from persistent chewing.</p><p><i>Surveillance:</i> Evaluation by a neurologist for epilepsy or if changes in behavior or regression of skills become evident; monitoring for lymphedema, which may appear in adolescence or adulthood; monitoring for symptoms of neurofibromatosis type 2 (NF2) in individuals with ring <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> 22.</p><p><i>Agents/circumstances to</i>
<i>avoid:</i> Exposure to high temperatures and extended periods in the sun because of decreased perspiration; exposure to dangers such as sources of excessive heat or cold, sharp objects, or clothes/shoes that are too tight, due to decreased perception of pain.</p></div><div><h4 class="inline">Genetic counseling.</h4><p>Phelan-McDermid syndrome, caused by a <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a> of 22q13.3 that includes at least a part of <i>SHANK3</i> or a <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in <i>SHANK3</i>, is inherited in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> manner. The deletion may be <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> or the result of a balanced <a class="def" href="/books/n/gene/glossary/def-item/translocation/">translocation</a> in one of the parents; pathogenic variants in <i>SHANK3</i> are almost always <i>de novo</i>. Prenatal testing and preimplantation diagnosis for Phelan-McDermid syndrome are possible for pregnancies at increased risk.</p></div></div><div id="gr_22q13_3.Diagnosis"><h2 id="_gr_22q13_3_Diagnosis_">Diagnosis</h2><p>No clinical diagnostic criteria have been established for Phelan-McDermid syndrome. The diagnosis is based on laboratory testing to establish a <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a> of 22q13 or a <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in <i>SHANK3</i>.</p><div id="gr_22q13_3.Suggestive_Findings"><h3>Suggestive Findings</h3><p>Phelan-McDermid syndrome <b>should be suspected</b> in children with the following:</p><ul><li class="half_rhythm"><div>Neonatal hypotonia</div></li><li class="half_rhythm"><div>Absent to severely delayed speech</div></li><li class="half_rhythm"><div>Developmental delay</div></li><li class="half_rhythm"><div>Minor <a class="def" href="/books/n/gene/glossary/def-item/dysmorphic/">dysmorphic</a> facial features including:</div><ul><li class="half_rhythm"><div>Dolichocephaly</div></li><li class="half_rhythm"><div>Full brow</div></li><li class="half_rhythm"><div>Flat midface</div></li><li class="half_rhythm"><div>Deep-set eyes</div></li><li class="half_rhythm"><div>Full or puffy eyelids</div></li><li class="half_rhythm"><div>Long eyelashes</div></li><li class="half_rhythm"><div>Wide nasal bridge</div></li><li class="half_rhythm"><div>Bulbous nose</div></li><li class="half_rhythm"><div>Full or puffy cheeks</div></li><li class="half_rhythm"><div>Large or prominent ears</div></li></ul></li></ul><p>Other features that raise suspicion of Phelan-McDermid syndrome include relatively large and fleshy hands, dysplastic toenails, sacral dimple, and decreased perspiration. As most <a class="def" href="/books/n/gene/glossary/def-item/autosomal/">autosomal</a> <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> disorders are associated with short stature with or without small head size, normal stature and normal head size distinguish Phelan-McDermid syndrome from other autosomal disorders. Behavior characteristics include mouthing or chewing non-food items, decreased perception of pain, and autism spectrum disorder or autistic-like affect and behavior.</p><p>Of note, most individuals with Phelan-McDermid syndrome are identified by <a class="def" href="/books/n/gene/glossary/def-item/chromosomal-microarray/">chromosomal microarray</a> analysis (CMA) performed in the context of evaluation for developmental delay, intellectual disability, and/or autism spectrum disorder.</p></div><div id="gr_22q13_3.Establishing_the_Diagnosis"><h3>Establishing the Diagnosis</h3><p>The diagnosis of Phelan-McDermid syndrome <b>is established</b> in a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> with typical clinical findings and detection of:</p><ul><li class="half_rhythm"><div>A &#x0003c;50-kb to &#x0003e;9-Mb <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a> at <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> 22q13.3 with involvement of at least part of <i>SHANK3</i>; OR</div></li><li class="half_rhythm"><div>A <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in <i>SHANK3</i> by <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> (see <a class="figpopup" href="/books/NBK1198/table/gr_22q13_3.T.molecular_genetic_testing_u/?report=objectonly" target="object" rid-figpopup="figgr22q133Tmoleculargenetictestingu" rid-ob="figobgr22q133Tmoleculargenetictestingu">Table 1</a>).</div></li></ul><p>Molecular testing approaches can include <b><a class="def" href="/books/n/gene/glossary/def-item/chromosomal-microarray/">chromosomal microarray</a> analysis (CMA)</b>, <b>single-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> testing</b>, and use of a <b><a class="def" href="/books/n/gene/glossary/def-item/multigene-panel/">multigene panel</a></b>:</p><ul><li class="half_rhythm"><div class="half_rhythm"><b>Chromosomal microarray analysis (CMA).</b> CMA should be the first genetic test as most cases of Phelan-McDermid syndrome are caused by large copy number variants (CNVs), which cannot be detected by <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a> of <i>SHANK3</i>. It is imperative that detection of deletions by CMA be followed by <a class="def" href="/books/n/gene/glossary/def-item/karyotype/">karyotype</a> screening for ring <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> detection.</div></li><li class="half_rhythm"><div class="half_rhythm"><b>Single-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> testing.</b> Gene-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a> of <i>SHANK3</i> is performed first and followed by <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a> of <i>SHANK3</i> if no deletion is found.</div></li><li class="half_rhythm"><div class="half_rhythm"><b>A <a class="def" href="/books/n/gene/glossary/def-item/multigene-panel/">multigene panel</a></b> that includes <i>SHANK3</i> and other genes of interest (see <a href="#gr_22q13_3.Differential_Diagnosis">Differential Diagnosis</a>) may be considered. Note: (1) The genes included in the panel and the diagnostic <a class="def" href="/books/n/gene/glossary/def-item/sensitivity/">sensitivity</a> of the testing used for each <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> vary by laboratory and are likely to change over time. (2) Some multigene panels may include genes not associated with the condition discussed in this <i>GeneReview</i>. (3) In some laboratories, panel options may include a custom laboratory-designed panel and/or custom <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a>-focused <a class="def" href="/books/n/gene/glossary/def-item/exome/">exome</a> analysis that includes genes specified by the clinician. (4) Methods used in a panel may include <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a>, <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a>, and/or other non-sequencing-based tests. For this disorder a multigene panel that also includes deletion/duplication analysis is recommended (see <a class="figpopup" href="/books/NBK1198/table/gr_22q13_3.T.molecular_genetic_testing_u/?report=objectonly" target="object" rid-figpopup="figgr22q133Tmoleculargenetictestingu" rid-ob="figobgr22q133Tmoleculargenetictestingu">Table 1</a>).</div><div class="half_rhythm">For an introduction to multigene panels click <a href="/books/n/gene/app5/#app5.Multigene_Panels">here</a>. More detailed information for clinicians ordering genetic tests can be found <a href="/books/n/gene/app5/#app5.Multigene_Panels_FAQs">here</a>.</div></li></ul><div id="gr_22q13_3.T.molecular_genetic_testing_u" class="table"><h3><span class="label">Table 1. </span></h3><div class="caption"><p>Molecular Genetic Testing Used in Phelan-McDermid Syndrome</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1198/table/gr_22q13_3.T.molecular_genetic_testing_u/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__gr_22q13_3.T.molecular_genetic_testing_u_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_gr_22q13_3.T.molecular_genetic_testing_u_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Gene&#x000a0;<sup>1</sup></th><th id="hd_h_gr_22q13_3.T.molecular_genetic_testing_u_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Method</th><th id="hd_h_gr_22q13_3.T.molecular_genetic_testing_u_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Proportion of Probands with a Pathogenic Variant&#x000a0;<sup>2</sup> Detectable by Method</th></tr></thead><tbody><tr><td headers="hd_h_gr_22q13_3.T.molecular_genetic_testing_u_1_1_1_1" rowspan="4" scope="row" colspan="1" style="text-align:left;vertical-align:middle;"><i>SHANK3</i></td><td headers="hd_h_gr_22q13_3.T.molecular_genetic_testing_u_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">CMA&#x000a0;<sup>3,&#x000a0;4</sup></td><td headers="hd_h_gr_22q13_3.T.molecular_genetic_testing_u_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">&#x0003e;97%&#x000a0;<sup>5,&#x000a0;6</sup></td></tr><tr><td headers="hd_h_gr_22q13_3.T.molecular_genetic_testing_u_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Karyotype</td><td headers="hd_h_gr_22q13_3.T.molecular_genetic_testing_u_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">See footnotes 7 and 8</td></tr><tr><td headers="hd_h_gr_22q13_3.T.molecular_genetic_testing_u_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Gene-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a>&#x000a0;<sup>5,&#x000a0;9</sup></td><td headers="hd_h_gr_22q13_3.T.molecular_genetic_testing_u_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Rare&#x000a0;<sup>10</sup></td></tr><tr><td headers="hd_h_gr_22q13_3.T.molecular_genetic_testing_u_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Sequence analysis&#x000a0;<sup>11</sup></td><td headers="hd_h_gr_22q13_3.T.molecular_genetic_testing_u_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">3%&#x000a0;<sup>6</sup></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt>1. </dt><dd><div id="gr_22q13_3.TF.1.1"><p class="no_margin">See <a href="/books/NBK1198/#gr_22q13_3.molgen.TA">Table A. Genes and Databases</a> for <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a> and protein.</p></div></dd><dt>2. </dt><dd><div id="gr_22q13_3.TF.1.2"><p class="no_margin">See <a href="#gr_22q13_3.Molecular_Genetics">Molecular Genetics</a> for information on allelic variants detected in this <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>.</p></div></dd><dt>3. </dt><dd><div id="gr_22q13_3.TF.1.3"><p class="no_margin"><a href="https://www.ncbi.nlm.nih.gov/projects/dbvar/clingen/clingen_gene.cgi?sym=SHANK3&#x00026;subject=" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">ClinGen-ISCA-3097</a>. Standardized clinical annotation and interpretation for <a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> variants from the <a href="http://www.clinicalgenome.org/about/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Clinical Genome Resource (ClinGen) project</a> (formerly the International Standards for Cytogenomic Arrays [ISCA] Consortium)</p></div></dd><dt>4. </dt><dd><div id="gr_22q13_3.TF.1.4"><p class="no_margin">Chromosomal microarray analysis (CMA) using oligonucleotide arrays or SNP arrays. CMA designs in current clinical use target the 22q13.3 region.</p></div></dd><dt>5. </dt><dd><div id="gr_22q13_3.TF.1.5"><p class="no_margin">Gene-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a>/<a class="def" href="/books/n/gene/glossary/def-item/duplication/">duplication</a> testing will detect deletions ranging from a single <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> to the whole <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>; however, breakpoints of large deletions and/or deletion of adjacent genes may not be detected by these methods.</p></div></dd><dt>6. </dt><dd><div id="gr_22q13_3.TF.1.6"><p class="no_margin">According to the Phelan-McDermid Syndrome Registry, of 232 individuals with microarray results, 181 (79%) have terminal or interstitial deletions, 41 (18%) have unbalanced translocations or other structural abnormalities leading to <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a>, and 7 (3%) have <i>SHANK3</i> pathogenic variants.</p></div></dd><dt>7. </dt><dd><div id="gr_22q13_3.TF.1.7"><p class="no_margin">Disruption of <i>SHANK3</i> resulting from a <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a>, apparently balanced <a class="def" href="/books/n/gene/glossary/def-item/translocation/">translocation</a> t(12;22)(q24.1;q13.3) was reported in a male with features of Phelan-McDermid syndrome [<a class="bk_pop" href="#gr_22q13_3.REF.bonaglia.2001.261">Bonaglia et al 2001</a>]. The breakpoints localized to <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> 22 within <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> 21 of <i>SHANK3</i> and to chromosome 12 within an <a class="def" href="/books/n/gene/glossary/def-item/intron/">intron</a> of <i>APPL2</i>.</p></div></dd><dt>8. </dt><dd><div id="gr_22q13_3.TF.1.8"><p class="no_margin">Although some 22q13 deletions may be visible by <a class="def" href="/books/n/gene/glossary/def-item/karyotype/">karyotype</a>, CMA is recommended to detect large deletions. Karyotype may be necessary to characterize complex rearrangements (e.g., recombinant chromosomes resulting from a parental inversion). Follow-up karyotype of deletions detected by CMA is essential because of the risk for <a href="/books/n/gene/nf2/">NF2</a> associated with ring chromosomes (ring chromosomes comprise ~10% of cases).</p></div></dd><dt>9. </dt><dd><div id="gr_22q13_3.TF.1.9"><p class="no_margin">Gene-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a> detects intragenic deletions or duplications. Methods used may include <a class="def" href="/books/n/gene/glossary/def-item/quantitative-pcr/">quantitative PCR</a>, long-range PCR, multiplex ligation-dependent probe amplification (MLPA), and a <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>-targeted microarray designed to detect single-<a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> deletions or duplications.</p></div></dd><dt>10. </dt><dd><div id="gr_22q13_3.TF.1.10"><p class="no_margin">Intragenic <i>SHANK3</i> deletions have been reported [<a class="bk_pop" href="#gr_22q13_3.REF.bonaglia.2011.e1002173">Bonaglia et al 2011</a>, <a class="bk_pop" href="#gr_22q13_3.REF.pinto.2014.677">Pinto et al 2014</a>, <a class="bk_pop" href="#gr_22q13_3.REF.tucker.2014.792">Tucker et al 2014</a>].</p></div></dd><dt>11. </dt><dd><div id="gr_22q13_3.TF.1.11"><p class="no_margin">Sequence analysis detects variants that are benign, likely benign, of <a class="def" href="/books/n/gene/glossary/def-item/uncertain-significance/">uncertain significance</a>, likely pathogenic, or pathogenic. Pathogenic variants may include small intragenic deletions/insertions and <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a>, <a class="def" href="/books/n/gene/glossary/def-item/nonsense-variant/">nonsense</a>, and <a class="def" href="/books/n/gene/glossary/def-item/splice-site/">splice site</a> variants; typically, <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> or whole-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> deletions/duplications are not detected. For issues to consider in interpretation of <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a> results, click <a href="/books/n/gene/app2/">here</a>.</p></div></dd></dl></div></div></div></div></div><div id="gr_22q13_3.Clinical_Characteristics"><h2 id="_gr_22q13_3_Clinical_Characteristics_">Clinical Characteristics</h2><div id="gr_22q13_3.Clinical_Description"><h3>Clinical Description</h3><p>Males and females are equally <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> with no apparent parent-of-origin effect (<a class="figpopup" href="/books/NBK1198/table/gr_22q13_3.T.features_of_phelanmcdermid/?report=objectonly" target="object" rid-figpopup="figgr22q133Tfeaturesofphelanmcdermid" rid-ob="figobgr22q133Tfeaturesofphelanmcdermid">Table 2</a>).</p><div id="gr_22q13_3.T.features_of_phelanmcdermid" class="table"><h3><span class="label">Table 2. </span></h3><div class="caption"><p>Features of Phelan-McDermid Syndrome</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1198/table/gr_22q13_3.T.features_of_phelanmcdermid/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__gr_22q13_3.T.features_of_phelanmcdermid_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_gr_22q13_3.T.features_of_phelanmcdermid_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Prevalence</th><th id="hd_h_gr_22q13_3.T.features_of_phelanmcdermid_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Features</th></tr></thead><tbody><tr><td headers="hd_h_gr_22q13_3.T.features_of_phelanmcdermid_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">&#x0003e;75%</td><td headers="hd_h_gr_22q13_3.T.features_of_phelanmcdermid_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Neonatal hypotonia</div></li><li class="half_rhythm"><div>Developmental delay</div></li><li class="half_rhythm"><div>Absent or severely delayed speech</div></li><li class="half_rhythm"><div>Normal growth</div></li><li class="half_rhythm"><div>Decreased perception of pain</div></li><li class="half_rhythm"><div>Mouthing /chewing / tooth grinding</div></li><li class="half_rhythm"><div>Autism / autistic-like behavior</div></li></ul>
</td></tr><tr><td headers="hd_h_gr_22q13_3.T.features_of_phelanmcdermid_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">&#x0003e;50%</td><td headers="hd_h_gr_22q13_3.T.features_of_phelanmcdermid_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Large, fleshy hands</div></li><li class="half_rhythm"><div>Dysplastic toenails</div></li><li class="half_rhythm"><div>Long eyelashes</div></li><li class="half_rhythm"><div>Hyperextensibility</div></li><li class="half_rhythm"><div>Prominent or large ears</div></li><li class="half_rhythm"><div>Full brow</div></li><li class="half_rhythm"><div>Full or puffy cheeks</div></li><li class="half_rhythm"><div>Full or puffy eyelids</div></li><li class="half_rhythm"><div>Deep-set eyes</div></li><li class="half_rhythm"><div>Flat midface</div></li><li class="half_rhythm"><div>Wide nasal bridge</div></li><li class="half_rhythm"><div>Bulbous nose</div></li><li class="half_rhythm"><div>Sacral dimple</div></li><li class="half_rhythm"><div>Decreased perspiration w/tendency to overheat</div></li><li class="half_rhythm"><div>Feeding difficulties</div></li></ul>
</td></tr><tr><td headers="hd_h_gr_22q13_3.T.features_of_phelanmcdermid_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">&#x0003e;25%</td><td headers="hd_h_gr_22q13_3.T.features_of_phelanmcdermid_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Dolichocephaly</div></li><li class="half_rhythm"><div>Strabismus</div></li><li class="half_rhythm"><div>Renal problems</div></li><li class="half_rhythm"><div>Gastroesophageal reflux</div></li><li class="half_rhythm"><div>Malocclusion / wide-spaced teeth</div></li><li class="half_rhythm"><div>Epicanthal folds</div></li><li class="half_rhythm"><div>High-arched palate</div></li><li class="half_rhythm"><div>Seizures</div></li></ul>
</td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div><p class="no_margin"><a class="bk_pop" href="#gr_22q13_3.REF.cusmanoozog.2007.393">Cusmano-Ozog et al [2007]</a>, <a class="bk_pop" href="#gr_22q13_3.REF.dhar.2010.573">Dhar et al [2010]</a>, <a class="bk_pop" href="#gr_22q13_3.REF.phelan.2010">Phelan et al [2010]</a></p></div></dd></dl></div></div></div><p><b>Hypotonia.</b> Newborns with Phelan-McDermid syndrome have generalized hypotonia that may be associated with weak cry, poor head control, and feeding difficulties leading to slow growth.</p><p><b>Developmental delay.</b> Most individuals with Phelan-McDermid syndrome are described as having "global developmental delay" or "moderate to profound intellectual disability." Although the severity of the delay tends to vary with <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a> size [<a class="bk_pop" href="#gr_22q13_3.REF.sarasua.2011.761">Sarasua et al 2011</a>, <a class="bk_pop" href="#gr_22q13_3.REF.zwanenburg.2016.16">Zwanenburg et al 2016</a>], individuals with the same size deletion may be vastly different in their degree of disability [<a class="bk_pop" href="#gr_22q13_3.REF.dhar.2010.573">Dhar et al 2010</a>]. Development assessment using the Developmental Profile II (DPII) and the Scales of Independent Behavior-Revised &#x02013; Full Scale (SIB-R) demonstrated that while all participants in the study of <a class="bk_pop" href="#gr_22q13_3.REF.wilson.2003.575">Wilson et al [2003]</a> had moderate to profound intellectual disability, compared to most children with this level of impairment, those with Phelan-McDermid syndrome had less frequent and less severe problematic behaviors. In an independent study based on the Bayley-II-NL scale of infant development, <a class="bk_pop" href="#gr_22q13_3.REF.zwanenburg.2016.16">Zwanenburg and colleagues [2016]</a> reported developmental delay with a maximum developmental age equivalent of 3 to 4.5 years and more pronounced delays in older individuals than in younger children, a trend referred as "growing into deficit."</p><p>Major milestones are delayed: the average age for rolling over is approximately eight months, for crawling approximately 16 months, and for walking approximately three years. Poor muscle tone, lack of balance, and decreased upper body strength contribute to the delay in walking. Gait is typically broad-based and unsteady. Individuals may walk on their toes to achieve balance.</p><p>Toilet training is difficult to achieve and requires extreme vigilance by parents and caregivers. Children may stay dry at night but become wet or soiled during the day because they are unable to communicate their needs.</p><p><b>Neurologic.</b> Arachnoid cysts occur in approximately 15% of individuals with Phelan-McDermid syndrome compared to an estimated 1% in the general population. Other neurologic problems include reduced myelination, frontal lobe hypoplasia, agenesis of the corpus callosum, ventriculomegaly, focal cortical atrophy, and seizures [<a class="bk_pop" href="#gr_22q13_3.REF.tabolacci.2005.127">Tabolacci et al 2005</a>].</p><p>Brain imaging studies on eight children with Phelan-McDermid syndrome revealed normal MRI in three children with the smallest <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a> size; four of the remaining five had thinning of the corpus callosum; and one of the five had atypical morphology of the corpus callosum [<a class="bk_pop" href="#gr_22q13_3.REF.philippe.2008.e376">Philippe et al 2008</a>]. PET studies of the eight children demonstrated localized dysfunction of the left temporal polar lobe and significant hypoperfusion of the amygdala compared to 13 children with <a class="def" href="/books/n/gene/glossary/def-item/idiopathic/">idiopathic</a> intellectual disability.</p><p>Between 25% and 50% have seizures, many of which are febrile and do not require medication; however, grand mal seizures, focal seizures, and absence seizures have been described. No characteristic EEG findings are associated with Phelan-McDermid syndrome.</p><p>Neurologic and motor regression has been reported by a number of parents of individuals with Phelan-McDermid syndrome. Loss of speech is most frequently reported but loss of self-help skills, social interactions, purposeful hand movements, and walking have also been described. In a study of 42 individuals age four to 48 years, <a class="bk_pop" href="#gr_22q13_3.REF.reierson.2017.139">Reierson et al [2017]</a> found that parents reported regression in 43% of individuals with onset around age six years. About 40% of individuals recovered skills; time to recovery ranged from one month to ten years. The ADI-R was used to characterize the regression and reported loss of:</p><ul><li class="half_rhythm"><div>Motor skills in 50% at mean age 4 years</div></li><li class="half_rhythm"><div>Self-help skill in 50% at mean age 4 years</div></li><li class="half_rhythm"><div>Language in 33% at mean age 3 years</div></li><li class="half_rhythm"><div>Social engagement/responsiveness in 33% at mean age 5 years</div></li><li class="half_rhythm"><div>Purposeful hand movement in 28% at mean age 7 years</div></li><li class="half_rhythm"><div>Constructive/imaginative play in 22% at mean age 7 years</div></li></ul><p>The regression in Phelan-McDermid syndrome is distinct from the regression seen in autism and <a href="/books/n/gene/rett/">Rett syndrome</a> in that it occurs later in life and has a stronger impact on motor skills and self-help skills [<a class="bk_pop" href="#gr_22q13_3.REF.reierson.2017.139">Reierson et al 2017</a>].</p><p><b>Behavior.</b>
<a class="bk_pop" href="#gr_22q13_3.REF.philippe.2008.e376">Philippe et al [2008]</a> examined the neurobehavioral profiles of eight children with Phelan-McDermid syndrome who ranged in age from four years, three months to 11 years, four months. Behavior problems included hyperactivity, short attention span, restlessness, clumsiness, ignorance of the consequences, resistance to change, and repetitive activities.</p><p>Other abnormal behaviors described in Phelan-McDermid syndrome include habitual chewing or mouthing, tooth grinding, decreased perception of pain, and sleep disturbance. Although sleep apnea is not a problem, <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals may have difficulty falling asleep and staying asleep. Affected individuals may become agitated in unfamiliar, noisy, or crowded surroundings.</p><p>While <a class="bk_pop" href="#gr_22q13_3.REF.philippe.2008.e376">Philippe et al [2008]</a> concluded that behavior exhibited by children with Phelan-McDermid syndrome did not meet the DSM IV criteria for autism spectrum disorder (ASD), other investigators have described the behavior as autistic or autistic-like with poor eye contact, stereotypic movements, and self-stimulation. More recently, <a class="bk_pop" href="#gr_22q13_3.REF.soorya.2013">Soorya et al [2013]</a> reported in a cohort of 32 individuals with Phelan-McDermid syndrome a high rate of individuals meeting criteria for autism spectrum disorder (84%) and for autistic disorder (75%). <a class="bk_pop" href="#gr_22q13_3.REF.oberman.2015.105">Oberman et al [2015]</a> evaluated the behavioral profile of 40 children with Phelan-McDermid syndrome and noted that the majority of individuals displayed persistent deficits in social communication, but only half met diagnostic criteria under the restricted, repetitive patterns of behavior, interests, or activities <a class="def" href="/books/n/gene/glossary/def-item/domain/">domain</a>. Furthermore, logistic regressions indicated that general developmental delay significantly contributed to the ASD diagnosis.</p><p>As a result of decreased perception of pain and lack of expressive communication skills, <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals may suffer cuts, scrapes, or even broken bones without indicating that they are in pain. They may suffer ear infections, gastroesophageal reflux, increased intracranial pressure, or other painful medical conditions without indicating discomfort.</p><p>Aggressive behavior including biting, hair pulling, or pinching is seen in approximately 25% of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals. The behavior is typically displayed when individuals are frustrated and may indicate that they are in pain but cannot express themselves appropriately. The behavior is not self-injurious but is often directed at the parent or caregiver.</p><p><b>Speech delay.</b> Infants typically babble at the appropriate age and children may acquire a limited vocabulary. However, by approximately age four years many children have lost the ability to speak. With intensive occupational, speech, and physical therapy they may regain speech and increase their vocabularies. Physical therapy strengthens muscle tone, improves coordination, and generally increases the individual's awareness of his/her surroundings. Although speech remains impaired throughout life, individuals can learn to communicate with the aid of aggressive therapy and communication training.</p><p>Receptive communication skills are more advanced than expressive language skills as evidenced by the ability of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> children to follow simple commands, demonstrate humor, and express emotions.</p><p><b>Hearing.</b> Individuals with Phelan-McDermid syndrome have a delayed response to verbal cues. They also have difficulty discerning spoken words from background noise. These two factors, along with the frequent occurrence of ear infections, contribute to the perception that hearing may be impaired. In fact, more than 80% of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals have normal hearing.</p><p><b>Vision.</b> Most <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals have normal vision, although hyperopia and myopia are observed. Cortical visual impairment, characterized by extensive use of peripheral vision, difficulty in processing cluttered images, problems with depth perception, and the tendency to look away from objects before reaching for them, has been reported in approximately 6% of affected individuals. The quality of vision fluctuates. Blindness and optic nerve hypoplasia have been associated with cortical visual impairment [<a class="bk_pop" href="#gr_22q13_3.REF.phelan.2010">Phelan et al 2010</a>].</p><p><b>Gastrointestinal.</b> Gastroesophageal reflux is seen in approximately 30% and cyclic vomiting in approximately 25% of individuals. Constipation and diarrhea are also reported. Precautions must be taken to avoid dehydration.</p><p><b>Renal.</b> The frequency of renal abnormalities has been reported as high as 38% [<a class="bk_pop" href="#gr_22q13_3.REF.soorya.2013">Soorya et al 2013</a>]. These include cystic kidneys, renal agenesis or dysplastic kidneys, hydronephrosis, vesicoureteral reflux, horseshoe kidney, and pyelectasis. Frequent urinary tract infections are also reported.</p><p><b>Growth.</b> Intrauterine growth in Phelan-McDermid syndrome is appropriate for gestational age; the mean gestational age is 38.2 weeks. Postnatal growth is normal. Height is often advanced for age but remains within two to three standard deviations from the mean. Weight is not increased so children appear tall and thin.</p><p>Whereas children may have increased height for age, adults tend to fall within the normal range for height. Most adults are also within the normal range for weight, although inactivity and overeating (possibly a manifestation of compulsive mouthing) result in increased weight gain in approximately 10% of individuals.</p><p>Head size is typically within normal range with microcephaly reported in about 11% of individuals [<a class="bk_pop" href="#gr_22q13_3.REF.rollins.2011.2324">Rollins et al 2011</a>].</p><p><b>Hypothyroidism</b> occurs in 3%-6% of individuals with this disorder [<a class="bk_pop" href="#gr_22q13_3.REF.soorya.2013">Soorya et al 2013</a>, <a class="bk_pop" href="#gr_22q13_3.REF.sarasua.2014b.847">Sarasua et al 2014b</a>]. Symptoms include lethargy, loss of interest, weight gain, and decline in skills and are typically manifested in the teenager or young adult. A thyroid panel should be obtained to rule out hypothyroidism.</p><p><b>Dental.</b> The most frequently encountered dental problems are malocclusion and crowding. Poor muscle tone, incessant chewing, tooth grinding, and tongue thrusting may contribute to malocclusion. Malocclusion may be accompanied by drooling and difficulty swallowing, and may contribute to difficulties in verbalization.</p><p><b>Lymphedema.</b> Both lymphedema and recurrent cellulitis have been observed in approximately 10% of individuals, typically becoming problematic during the teen and adult years. Progressive lymphedema leading to pleural effusions has been reported in a female with Phelan-McDermid syndrome resulting from a ring <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> r(22)(p11.2q12.3) [<a class="bk_pop" href="#gr_22q13_3.REF.mcgaughran.2010.28">McGaughran et al 2010</a>].</p><p><b>Craniofacial.</b> Among the most common and striking craniofacial features are dolichocephaly, large or prominent ears, epicanthal folds, long eyelashes, supraorbital fullness, full cheeks, and short or bulbous nose. More subtle features are deep-set eyes, flat midface, full brow, and wide nasal bridge. The features may change over time, particularly if the individual is on anticonvulsants that tend to coarsen the features. Adults have a more prominent, square jaw and less bulbous-appearing nose.</p><p><b>Cardiac.</b> Various <a class="def" href="/books/n/gene/glossary/def-item/congenital/">congenital</a> heart defects have been reported, including aortic regurgitation, patent ductus arteriosus, total anomalous venous return, atrial septal defect, and tricuspid valve regurgitation; estimates of the incidence of congenital heart defects range from 3% to 25% [<a class="bk_pop" href="#gr_22q13_3.REF.phelan.2012.186">Phelan &#x00026; McDermid 2012</a>, <a class="bk_pop" href="#gr_22q13_3.REF.soorya.2013">Soorya et al 2013</a>, <a class="bk_pop" href="#gr_22q13_3.REF.kolevzon.2014a.39">Kolevzon et al 2014a</a>]. <a class="bk_pop" href="#gr_22q13_3.REF.kolevzon.2014a.39">Kolevzon et al [2014a]</a> recommend that the initial workup of an individual with Phelan-McDermid syndrome include a standard cardiac evaluation with echocardiograph and electrocardiography to detect defects requiring medical and/or surgical intervention.</p><p><b>Other</b></p><ul><li class="half_rhythm"><div>The hands appear large and fleshy.</div></li><li class="half_rhythm"><div>Toenails are often dysplastic, thin, and flaky and tend to become ingrown. Fingernails are usually normal.</div></li><li class="half_rhythm"><div>An atypical teratoid/rhabdoid tumor has been reported in at least three cases: an infant with a 7.2-Mb <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a> of 22q13 [<a class="bk_pop" href="#gr_22q13_3.REF.sathyamoorthi.2009.1067">Sathyamoorthi et al 2009</a>], a girl age four years with a ring 22 [<a class="bk_pop" href="#gr_22q13_3.REF.rubio.1997.1027">Rubio 1997</a>], and a boy age four months with a ring 22 [<a class="bk_pop" href="#gr_22q13_3.REF.cho.2014.333">Cho et al 2014</a>].</div></li><li class="half_rhythm"><div><a href="/books/n/gene/mld/">Arylsulfatase A deficiency</a> (metachromatic leukodystrophy) was observed in a child with <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a> 22q13 and mutation of <i>ARSA</i> on the homologous <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> 22 [<a class="bk_pop" href="#gr_22q13_3.REF.bisgaard.2009.175">Bisgaard et al 2009</a>].</div></li></ul><p><b>Adulthood.</b> Longitudinal data are insufficient to determine life expectancy. However, life-threatening or life-shortening cardiac, pulmonary, or other organ system defects are not common. The paucity of older adults with Phelan-McDermid syndrome reflects the difficulty in establishing the diagnosis prior to the advent of high-resolution <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> analysis, <a class="def" href="/books/n/gene/glossary/def-item/fish/">FISH</a>, and CMA.</p><p>In older individuals, behavioral problems tend to subside, developmental abilities improve, and some features such as large or fleshy hands, full or puffy eyelids, hypotonia, lax ligaments, and hyperextensible joints are reported as less frequent [<a class="bk_pop" href="#gr_22q13_3.REF.sarasua.2014b.847">Sarasua et al 2014b</a>]. Late-onset seizures, unexplained weight loss, and loss of motor skills may occur in older individuals, adversely affecting quality of life.</p><p><b>Ring <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> 22.</b> Individuals with Phelan-McDermid syndrome as a result of ring chromosome 22 have a specific risk of developing <a href="/books/n/gene/nf2/">neurofibromatosis type 2</a> (NF2).</p><p><i>NF2</i> (pathogenic variants in which cause NF2) is at 22q12.2 adjacent to the Phelan-McDermid syndrome <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a> region. The risk for NF2 is due to the instability of ring chromosomes during mitosis and follows a two-hit model. The first hit is the loss of the ring <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> 22 during mitosis, making a cell <a class="def" href="/books/n/gene/glossary/def-item/hemizygous/">hemizygous</a> for chromosome 22. The second hit is a somatic mutation of the remaining NF2 <a class="def" href="/books/n/gene/glossary/def-item/allele/">allele</a> [<a class="bk_pop" href="#gr_22q13_3.REF.zirn.2012.82">Zirn et al 2012</a>].</p><p>Children with ring <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> 22 should be monitored for NF2 in the same manner as if they had an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> parent. This includes baseline and annual ocular, dermal, and neurologic examinations between ages two and ten years with annual audiology screening and brain MRI every two years after age ten years [<a class="bk_pop" href="#gr_22q13_3.REF.lyonswarren.2017.e205">Lyons-Warren et al 2017</a>].</p><p><b>Mosaic 22q13.3 <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a>.</b> Mosaic 22q13.3 deletion has been reported on occasion. The level of <a class="def" href="/books/n/gene/glossary/def-item/mosaicism/">mosaicism</a> for 22q13.3 deletion varies among <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals. Note: Because most testing is performed on blood samples, because the level of mosaicism in blood can change over time, and because the level of mosaicism in the blood is not representative of the level of mosaicism in the brain and other tissues, the level of mosaicism that is sufficient for expression of the major features of Phelan-McDermid syndrome is unknown.</p><p>Mosaicism is particularly common in 22q13 <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a> associated with ring chromosomes because of the instability of the ring structure during cell division.</p><ul><li class="half_rhythm"><div>One adult with characteristic features of Phelan-McDermid syndrome showed ring 22 in only 8% of blood cells [Phelan, unpublished data].</div></li><li class="half_rhythm"><div><a class="bk_pop" href="#gr_22q13_3.REF.bonaglia.2009.426">Bonaglia et al [2009]</a> reported <a class="def" href="/books/n/gene/glossary/def-item/mosaicism/">mosaicism</a> for ring <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> 22 in two individuals with deletions of 8.8-8.9 Mb. The first individual had a ring derived from the maternal chromosome 22 in 45% of cells as well as paternal isodisomy for the segment 22q13.2-qter, which resulted from <a class="def" href="/books/n/gene/glossary/def-item/gene-conversion/">gene conversion</a> in the cells that did not have the ring chromosome 22. The second individual had a ring derived from the paternal chromosome 22 in 73% of peripheral blood cells. Psychomotor delay was more severe in the second individual than in the first.</div></li></ul><p>In at least three instances <a class="def" href="/books/n/gene/glossary/def-item/mosaicism/">mosaicism</a> in asymptomatic mothers resulted in Phelan-McDermid syndrome in their offspring:</p><ul><li class="half_rhythm"><div>Two brothers with features suggestive of Clark-Baraitser syndrome (see <a href="#gr_22q13_3.Differential_Diagnosis">Differential Diagnosis</a>) were found to have <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a> of approximately 3.5 Mb at 22q13. It was inferred that the deletion had been inherited from the mother because the brothers had not inherited the same paternal <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> 22 [<a class="bk_pop" href="#gr_22q13_3.REF.tabolacci.2005.127">Tabolacci et al 2005</a>].</div></li><li class="half_rhythm"><div>A phenotypically normal mother of two <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> children was mosaic for <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a> 22q13.3, resulting from an unbalanced <a class="def" href="/books/n/gene/glossary/def-item/translocation/">translocation</a> with the satellite region of an unidentified acrocentric <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a>. The derivative chromosome 22 was observed in 6% of cells from maternal peripheral blood [Phelan, unpublished data].</div></li><li class="half_rhythm"><div>The mother of a child with non-mosaic ring <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> 22 had ring chromosome 22 in fewer than 2% of peripheral blood cells [Phelan, unpublished data].</div></li></ul></div><div id="gr_22q13_3.GenotypePhenotype_Correlation"><h3>Genotype-Phenotype Correlations</h3><p>Although several studies to determine <a class="def" href="/books/n/gene/glossary/def-item/genotype-phenotype-correlations/">genotype-phenotype correlations</a> in those with Phelan-McDermid syndrome failed to show a relationship between <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a> size and severity of features, the study by <a class="bk_pop" href="#gr_22q13_3.REF.wilson.2003.575">Wilson et al [2003]</a> reported a statistically significant correlation between deletion size and the degree of developmental delay and severity of hypotonia.</p><p>More recent analyses indicated that larger deletions were associated with increased likelihood of <a class="def" href="/books/n/gene/glossary/def-item/dysmorphic/">dysmorphic</a> features and medical comorbidities, while small deletions or <i>SHANK3</i> pathogenic variants correlated with autism spectrum disorder, seizures, hypotonia, sleep disturbances, abnormal brain MRI, gastroesophageal reflux, and certain dysmorphic features [<a class="bk_pop" href="#gr_22q13_3.REF.soorya.2013">Soorya et al 2013</a>]. <a class="bk_pop" href="#gr_22q13_3.REF.sarasua.2014a.318">Sarasua et al [2014a]</a> and <a class="bk_pop" href="#gr_22q13_3.REF.sarasua.2014b.847">Sarasua et al [2014b]</a> confirmed the trend correlating larger deletions with more severe clinical presentations and smaller deletions with autism spectrum disorder, and also identified specific loci and candidate genes within the 22q13.2q13.32 region associated with certain features of the Phelan-McDermid syndrome: severity of speech/language delay, neonatal hypotonia, delayed age at walking, hair-pulling behaviors, male genital anomalies, dysplastic toenails, large/fleshy hands, macrocephaly, short and tall stature, facial asymmetry, and atypical reflexes. Although there is a tendency for larger deletions to be correlated with more severe intellectual and physical phenotypes than smaller deletions, the correlation is not 100%; individuals with the same size <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a> may vary significantly in their presentation [<a class="bk_pop" href="#gr_22q13_3.REF.dhar.2010.573">Dhar et al 2010</a>].</p></div><div id="gr_22q13_3.Penetrance"><h3>Penetrance</h3><p>Although it was previously thought that features of Phelan-McDermid syndrome were apparent in all individuals with non-mosaic 22q13.3 <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a> that include <i>SHANK3</i>, recent evidence suggests that small deletions involving <i>SHANK3</i> may be associated with non-<a class="def" href="/books/n/gene/glossary/def-item/penetrance/">penetrance</a> and <a class="def" href="/books/n/gene/glossary/def-item/variable-expressivity/">variable expressivity</a> (see <a class="bk_pop" href="#gr_22q13_3.REF.tabet.2017.32">Tabet et al [2017]</a>)<i>.</i> Pathogenic variants in <i>SHANK3</i> have been associated with Phelan-McDermid syndrome, nonsyndromic autism, and schizophrenia.</p><ul><li class="half_rhythm"><div><a class="bk_pop" href="#gr_22q13_3.REF.tabet.2017.32">Tabet et al [2017]</a> described a multiplex family in which the mother and five of six daughters had a 67-kb <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a> of <i>SHANK3</i>. The <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> was diagnosed with Phelan-McDermid syndrome and her sisters had delayed speech with or without mild to moderate intellectual disability. CNVs of two other genes, <i>NRXN1</i> and <i>KAL1</i>, were also segregating in the family and were thought to contribute to the phenotypic variability, perhaps by modulating the effect of the <i>SHANK3</i> deletion.</div></li><li class="half_rhythm"><div>Full manifestation of features has been seen in individuals with as low as 8% <a class="def" href="/books/n/gene/glossary/def-item/mosaicism/">mosaicism</a> for the 22q13.3 <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a> in peripheral blood [Phelan, personal observation].</div></li></ul></div><div id="gr_22q13_3.Nomenclature"><h3>Nomenclature</h3><p>Previously referred to as 22q13.3 <a class="def" href="/books/n/gene/glossary/def-item/deletion-syndrome/">deletion syndrome</a> to reflect the chromosomal basis of this deletion, the condition is now commonly called Phelan-McDermid syndrome, a more comprehensive term that includes individuals with 22q13.3 deletion and those without a detectable deletion who have a <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in <i>SHANK3</i>.</p></div><div id="gr_22q13_3.Prevalence"><h3>Prevalence</h3><p>The prevalence of Phelan-McDermid syndrome is unknown. More than 1,500 individuals are registered with the Phelan-McDermid Syndrome Foundation (Venice, Florida, 2017). This does not represent the total number of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals, as not all families worldwide register with the foundation.</p></div></div><div id="gr_22q13_3.Genetically_Related_Disorders"><h2 id="_gr_22q13_3_Genetically_Related_Disorders_">Genetically Related Disorders</h2><p><i>SHANK3</i> pathogenic variants are observed in autism spectrum disorder.</p><ul><li class="half_rhythm"><div>In their investigation of autism spectrum disorder (ASD), <a class="bk_pop" href="#gr_22q13_3.REF.durand.2007.25">Durand et al [2007]</a> identified two brothers with autism, severely delayed speech, and severe intellectual disability without other findings to suggest Phelan-McDermid syndrome who were <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> for a pathogenic <a class="def" href="/books/n/gene/glossary/def-item/frameshift-variant/">frameshift variant</a>. Neither the parents nor an unaffected brother had the <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>. Results of molecular studies suggested maternal <a class="def" href="/books/n/gene/glossary/def-item/germline-mosaicism/">germline mosaicism</a>.</div></li><li class="half_rhythm"><div><a class="bk_pop" href="#gr_22q13_3.REF.gauthier.2009.421">Gauthier et al [2009]</a> screened the entire <a class="def" href="/books/n/gene/glossary/def-item/coding-region/">coding region</a> and <a class="def" href="/books/n/gene/glossary/def-item/intronic/">intronic</a> splice junctions of <i>SHANK3</i> in 427 individuals with ASD. They found two novel variants in <i>SHANK3</i> supporting the role of this <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> in ASD.</div></li><li class="half_rhythm"><div>Testing for 22q13.3 and <i>SHANK3</i> deletions/pathogenic variants are often included in panels designed for testing of individuals with autism spectrum disorder.</div></li></ul><p><i>SHANK3</i> pathogenic variants have also been reported in patients with schizophrenia, intellectual disability, bipolar disorders, and <a href="/books/n/gene/alzheimer/">Alzheimer disease</a> [<a class="bk_pop" href="#gr_22q13_3.REF.guilmatre.2014.113">Guilmatre et al 2014</a>].</p></div><div id="gr_22q13_3.Differential_Diagnosis"><h2 id="_gr_22q13_3_Differential_Diagnosis_">Differential Diagnosis</h2><div id="gr_22q13_3.T.disorders_to_consider_in_th" class="table"><h3><span class="label">Table 3. </span></h3><div class="caption"><p>Disorders to Consider in the Differential Diagnosis of Phelan-McDermid Syndrome</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1198/table/gr_22q13_3.T.disorders_to_consider_in_th/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__gr_22q13_3.T.disorders_to_consider_in_th_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_gr_22q13_3.T.disorders_to_consider_in_th_1_1_1_1" rowspan="2" scope="col" colspan="1" headers="hd_h_gr_22q13_3.T.disorders_to_consider_in_th_1_1_1_1" style="text-align:left;vertical-align:middle;">Differential Diagnosis Disorder</th><th id="hd_h_gr_22q13_3.T.disorders_to_consider_in_th_1_1_1_2" rowspan="2" scope="col" colspan="1" headers="hd_h_gr_22q13_3.T.disorders_to_consider_in_th_1_1_1_2" style="text-align:left;vertical-align:middle;">Gene / Genetic Mechanism</th><th id="hd_h_gr_22q13_3.T.disorders_to_consider_in_th_1_1_1_3" rowspan="2" scope="col" colspan="1" headers="hd_h_gr_22q13_3.T.disorders_to_consider_in_th_1_1_1_3" style="text-align:center;vertical-align:middle;">MOI</th><th id="hd_h_gr_22q13_3.T.disorders_to_consider_in_th_1_1_1_4" colspan="2" scope="colgroup" rowspan="1" style="text-align:center;vertical-align:middle;">Clinical Features of the Differential Diagnosis Disorder</th></tr><tr><th headers="hd_h_gr_22q13_3.T.disorders_to_consider_in_th_1_1_1_4" id="hd_h_gr_22q13_3.T.disorders_to_consider_in_th_1_1_2_1" colspan="1" scope="colgroup" rowspan="1" style="text-align:left;vertical-align:middle;">Overlapping w/Phelan-McDermid syndrome</th><th headers="hd_h_gr_22q13_3.T.disorders_to_consider_in_th_1_1_1_4" id="hd_h_gr_22q13_3.T.disorders_to_consider_in_th_1_1_2_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Distinguishing from Phelan-McDermid syndrome</th></tr></thead><tbody><tr><td headers="hd_h_gr_22q13_3.T.disorders_to_consider_in_th_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/pws/">Prader-Willi syndrome</a></td><td headers="hd_h_gr_22q13_3.T.disorders_to_consider_in_th_1_1_1_2 hd_h_gr_22q13_3.T.disorders_to_consider_in_th_1_1_1_3" colspan="2" rowspan="1" style="text-align:left;vertical-align:middle;">See footnote 1</td><td headers="hd_h_gr_22q13_3.T.disorders_to_consider_in_th_1_1_1_4 hd_h_gr_22q13_3.T.disorders_to_consider_in_th_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Neonatal hypotonia</div></li><li class="half_rhythm"><div>Feeding difficulty</div></li><li class="half_rhythm"><div>Intellectual deficit</div></li><li class="half_rhythm"><div>Strabismus</div></li></ul>
</td><td headers="hd_h_gr_22q13_3.T.disorders_to_consider_in_th_1_1_1_4 hd_h_gr_22q13_3.T.disorders_to_consider_in_th_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>&#x02191; appetite w/significant weight gain</div></li><li class="half_rhythm"><div>Dolichocephaly, narrow bitemporal diameter</div></li><li class="half_rhythm"><div>Almond-shaped eyes, strabismus</div></li><li class="half_rhythm"><div>Small-appearing mouth w/thin upper lip &#x00026; down-turned corners</div></li><li class="half_rhythm"><div>Small hands &#x00026; feet</div></li><li class="half_rhythm"><div>Hypernasal speech, weak or squeaky cry in infancy</div></li><li class="half_rhythm"><div>Hypogonadism</div></li></ul>
</td></tr><tr><td headers="hd_h_gr_22q13_3.T.disorders_to_consider_in_th_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/angelman/">Angelman syndrome</a></td><td headers="hd_h_gr_22q13_3.T.disorders_to_consider_in_th_1_1_1_2 hd_h_gr_22q13_3.T.disorders_to_consider_in_th_1_1_1_3" colspan="2" rowspan="1" style="text-align:left;vertical-align:middle;">See footnote 2</td><td headers="hd_h_gr_22q13_3.T.disorders_to_consider_in_th_1_1_1_4 hd_h_gr_22q13_3.T.disorders_to_consider_in_th_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Infantile hypotonia</div></li><li class="half_rhythm"><div>DD</div></li><li class="half_rhythm"><div>Absent speech</div></li><li class="half_rhythm"><div>Unsteady gait</div></li><li class="half_rhythm"><div>Minor <a class="def" href="/books/n/gene/glossary/def-item/dysmorphic/">dysmorphic</a> features</div></li></ul>
</td><td headers="hd_h_gr_22q13_3.T.disorders_to_consider_in_th_1_1_1_4 hd_h_gr_22q13_3.T.disorders_to_consider_in_th_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Microcephaly w/flat occiput</div></li><li class="half_rhythm"><div>Ataxia</div></li><li class="half_rhythm"><div>Paroxysmal laughter, easily excitable</div></li></ul>
</td></tr><tr><td headers="hd_h_gr_22q13_3.T.disorders_to_consider_in_th_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Velocardiofacial syndrome<br />(see <a href="/books/n/gene/gr_22q11deletion/">22q11.2 Deletion Syndrome</a>)</td><td headers="hd_h_gr_22q13_3.T.disorders_to_consider_in_th_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">22q11.2 <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a></td><td headers="hd_h_gr_22q13_3.T.disorders_to_consider_in_th_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AD</td><td headers="hd_h_gr_22q13_3.T.disorders_to_consider_in_th_1_1_1_4 hd_h_gr_22q13_3.T.disorders_to_consider_in_th_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Hypotonia</div></li><li class="half_rhythm"><div>Epicanthal folds</div></li><li class="half_rhythm"><div>Narrow palpebral fissures</div></li><li class="half_rhythm"><div>Broad nasal root</div></li><li class="half_rhythm"><div>Speech delay</div></li><li class="half_rhythm"><div>Renal abnormalities</div></li><li class="half_rhythm"><div>DD</div></li></ul>
</td><td headers="hd_h_gr_22q13_3.T.disorders_to_consider_in_th_1_1_1_4 hd_h_gr_22q13_3.T.disorders_to_consider_in_th_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Cardiac defects</div></li><li class="half_rhythm"><div>Palatal defects</div></li><li class="half_rhythm"><div>Immune deficiency</div></li><li class="half_rhythm"><div>Hypocalcemia</div></li><li class="half_rhythm"><div>Milder neurologic signs</div></li></ul>
</td></tr><tr><td headers="hd_h_gr_22q13_3.T.disorders_to_consider_in_th_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/williams/">Williams syndrome</a></td><td headers="hd_h_gr_22q13_3.T.disorders_to_consider_in_th_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">7q11.23 <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a>&#x000a0;<sup>3</sup></td><td headers="hd_h_gr_22q13_3.T.disorders_to_consider_in_th_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AD</td><td headers="hd_h_gr_22q13_3.T.disorders_to_consider_in_th_1_1_1_4 hd_h_gr_22q13_3.T.disorders_to_consider_in_th_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Hypotonia</div></li><li class="half_rhythm"><div>DD</div></li><li class="half_rhythm"><div>Puffy eyelids</div></li></ul>
</td><td headers="hd_h_gr_22q13_3.T.disorders_to_consider_in_th_1_1_1_4 hd_h_gr_22q13_3.T.disorders_to_consider_in_th_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Cardiovascular anomalies&#x000a0;<sup>4</sup></div></li><li class="half_rhythm"><div>Endocrine abnormalities&#x000a0;<sup>5</sup></div></li></ul>
</td></tr><tr><td headers="hd_h_gr_22q13_3.T.disorders_to_consider_in_th_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/tps/">Trichorhinophalangeal syndrome</a></td><td headers="hd_h_gr_22q13_3.T.disorders_to_consider_in_th_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>TRPS1</i><br />8q23.3q24.11 <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a>&#x000a0;<sup>6</sup></td><td headers="hd_h_gr_22q13_3.T.disorders_to_consider_in_th_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AD</td><td headers="hd_h_gr_22q13_3.T.disorders_to_consider_in_th_1_1_1_4 hd_h_gr_22q13_3.T.disorders_to_consider_in_th_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Hypotonia</div></li><li class="half_rhythm"><div>Intellectual deficit</div></li><li class="half_rhythm"><div>Bulbous nose</div></li><li class="half_rhythm"><div>Large or prominent ears</div></li><li class="half_rhythm"><div>Deep-set eyes</div></li><li class="half_rhythm"><div>Thin hypoplastic toenails</div></li></ul>
</td><td headers="hd_h_gr_22q13_3.T.disorders_to_consider_in_th_1_1_1_4 hd_h_gr_22q13_3.T.disorders_to_consider_in_th_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Multiple cartilagineous exostoses</div></li><li class="half_rhythm"><div>Redundant skin</div></li><li class="half_rhythm"><div>Prominent philtrum, thin upper lip, sparse hair, small jaw</div></li><li class="half_rhythm"><div>Growth restriction</div></li></ul>
</td></tr><tr><td headers="hd_h_gr_22q13_3.T.disorders_to_consider_in_th_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/sms/">Smith-Magenis syndrome</a></td><td headers="hd_h_gr_22q13_3.T.disorders_to_consider_in_th_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>RAI1</i><br />17p11.2 <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a>&#x000a0;<sup>7</sup></td><td headers="hd_h_gr_22q13_3.T.disorders_to_consider_in_th_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AD&#x000a0;<sup>8</sup></td><td headers="hd_h_gr_22q13_3.T.disorders_to_consider_in_th_1_1_1_4 hd_h_gr_22q13_3.T.disorders_to_consider_in_th_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Hypotonia</div></li><li class="half_rhythm"><div>Speech delay</div></li><li class="half_rhythm"><div>Psychomotor retardation</div></li><li class="half_rhythm"><div>Flat midface</div></li><li class="half_rhythm"><div>&#x02193; sensitivity to pain</div></li></ul>
</td><td headers="hd_h_gr_22q13_3.T.disorders_to_consider_in_th_1_1_1_4 hd_h_gr_22q13_3.T.disorders_to_consider_in_th_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Inattention &#x00026; hyperactivity</div></li><li class="half_rhythm"><div>Distinctive facial features</div></li><li class="half_rhythm"><div>Behavioral abnormalities&#x000a0;<sup>9</sup></div></li></ul>
</td></tr><tr><td headers="hd_h_gr_22q13_3.T.disorders_to_consider_in_th_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Fragile X syndrome<br />(see <a href="/books/n/gene/fragilex/"><i>FMR1-</i>Related Disorders</a>)</td><td headers="hd_h_gr_22q13_3.T.disorders_to_consider_in_th_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>FMR1</i></td><td headers="hd_h_gr_22q13_3.T.disorders_to_consider_in_th_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">XL</td><td headers="hd_h_gr_22q13_3.T.disorders_to_consider_in_th_1_1_1_4 hd_h_gr_22q13_3.T.disorders_to_consider_in_th_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Hypotonia</div></li><li class="half_rhythm"><div>Speech delay</div></li><li class="half_rhythm"><div>Autistic-like behavior</div></li><li class="half_rhythm"><div>DD</div></li></ul>
</td><td headers="hd_h_gr_22q13_3.T.disorders_to_consider_in_th_1_1_1_4 hd_h_gr_22q13_3.T.disorders_to_consider_in_th_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Large head, long face, prominent forehead &#x00026; chin, protruding ears</div></li><li class="half_rhythm"><div>Connective tissue findings (joint laxity)</div></li><li class="half_rhythm"><div>Large testes (post-pubertally)</div></li></ul>
</td></tr><tr><td headers="hd_h_gr_22q13_3.T.disorders_to_consider_in_th_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">FG syndrome<br />(see <a href="/books/n/gene/fg/"><i>MED12</i>-Related Disorders</a>)</td><td headers="hd_h_gr_22q13_3.T.disorders_to_consider_in_th_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>MED12</i></td><td headers="hd_h_gr_22q13_3.T.disorders_to_consider_in_th_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">XL</td><td headers="hd_h_gr_22q13_3.T.disorders_to_consider_in_th_1_1_1_4 hd_h_gr_22q13_3.T.disorders_to_consider_in_th_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Hypotonia</div></li><li class="half_rhythm"><div>ID</div></li><li class="half_rhythm"><div>Delayed speech</div></li><li class="half_rhythm"><div>Autistic-like behavior</div></li><li class="half_rhythm"><div>Gastroesophageal reflux</div></li></ul>
</td><td headers="hd_h_gr_22q13_3.T.disorders_to_consider_in_th_1_1_1_4 hd_h_gr_22q13_3.T.disorders_to_consider_in_th_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Intestinal/anal atresia</div></li><li class="half_rhythm"><div>Chronic constipation</div></li><li class="half_rhythm"><div>Short stature</div></li><li class="half_rhythm"><div>Vertebral malformations</div></li><li class="half_rhythm"><div>Simple low-set ears</div></li><li class="half_rhythm"><div>Characteristic personality traits incl outgoing, talkative, &#x00026; impulsive behavior</div></li></ul>
</td></tr><tr><td headers="hd_h_gr_22q13_3.T.disorders_to_consider_in_th_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/sotos/">Sotos syndrome</a></td><td headers="hd_h_gr_22q13_3.T.disorders_to_consider_in_th_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>NSD1</i></td><td headers="hd_h_gr_22q13_3.T.disorders_to_consider_in_th_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AD</td><td headers="hd_h_gr_22q13_3.T.disorders_to_consider_in_th_1_1_1_4 hd_h_gr_22q13_3.T.disorders_to_consider_in_th_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Neonatal hypotonia &#x00026; difficulty feeding</div></li><li class="half_rhythm"><div>Mild ID</div></li><li class="half_rhythm"><div>Delays in motor development</div></li><li class="half_rhythm"><div>Dysmorphic features incl dolicocephaly, pointed chin, large hands</div></li><li class="half_rhythm"><div>Autistic-like behavior</div></li><li class="half_rhythm"><div>Receptive language skills more advanced than expressive language skills</div></li><li class="half_rhythm"><div>Attention deficit disorder &#x00026;/or aggressiveness</div></li></ul>
</td><td headers="hd_h_gr_22q13_3.T.disorders_to_consider_in_th_1_1_1_4 hd_h_gr_22q13_3.T.disorders_to_consider_in_th_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Affected children become more similar to their peers w/age.</td></tr><tr><td headers="hd_h_gr_22q13_3.T.disorders_to_consider_in_th_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Clark-Baraitser syndrome<br />(OMIM <a href="https://omim.org/entry/300602" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">300602</a>)</td><td headers="hd_h_gr_22q13_3.T.disorders_to_consider_in_th_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Unknown</td><td headers="hd_h_gr_22q13_3.T.disorders_to_consider_in_th_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">XL&#x000a0;<sup>10</sup></td><td headers="hd_h_gr_22q13_3.T.disorders_to_consider_in_th_1_1_1_4 hd_h_gr_22q13_3.T.disorders_to_consider_in_th_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>ID</div></li><li class="half_rhythm"><div>Thick hands &#x00026; feet</div></li></ul>
</td><td headers="hd_h_gr_22q13_3.T.disorders_to_consider_in_th_1_1_1_4 hd_h_gr_22q13_3.T.disorders_to_consider_in_th_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Absence of hypotonia</div></li><li class="half_rhythm"><div>Obesity</div></li><li class="half_rhythm"><div>Macroorchidism</div></li></ul>
</td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div><p class="no_margin">AD = <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a>; AR = <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a>; DD = developmental delay; ID = intellectual disability; MOI = <a class="def" href="/books/n/gene/glossary/def-item/mode-of-inheritance/">mode of inheritance</a>; XL = <a class="def" href="/books/n/gene/glossary/def-item/x-linked/">X-linked</a></p></div></dd><dt>1. </dt><dd><div id="gr_22q13_3.TF.3.1"><p class="no_margin">PWS is caused by an absence of expression of <a class="def" href="/books/n/gene/glossary/def-item/imprinted/">imprinted</a> genes in the paternally derived PWS / Angelman syndrome (AS) region (i.e., 15q11.2-q13) of <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> 15 by one of several genetic mechanisms (paternal <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a>, maternal <a class="def" href="/books/n/gene/glossary/def-item/uniparental-disomy/">uniparental disomy</a> (UPD) 15, and, rarely, an <a class="def" href="/books/n/gene/glossary/def-item/imprinting/">imprinting</a> defect). The risk to the sibs of an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> child of having PWS depends on the genetic mechanism that resulted in the absence of expression of the paternally contributed 15q11.2-q13 region. The risk to sibs is typically less than 1% if the affected child has a deletion or UPD, up to 50% if the affected child has an imprinting defect, and up to 25% if a parental chromosome <a class="def" href="/books/n/gene/glossary/def-item/translocation/">translocation</a> is present.</p></div></dd><dt>2. </dt><dd><div id="gr_22q13_3.TF.3.2"><p class="no_margin">Angelman syndrome is caused by disruption of maternally <a class="def" href="/books/n/gene/glossary/def-item/imprinted/">imprinted</a> <i>UBE3A</i> located within the 15q11.2-q13 Angelman syndrome / Prader-Willi syndrome (AS/PWS) region. The risk to sibs of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> depends on the genetic mechanism leading to the loss of <i>UBE3A</i> function: typically less than 1% risk for probands with a <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a> or UPD, and as high as 50% for probands with an ID or a <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> of <i>UBE3A3.</i></p></div></dd><dt>3. </dt><dd><div id="gr_22q13_3.TF.3.3"><p class="no_margin">Williams syndrome is caused by a recurrent 7q11.23 <a class="def" href="/books/n/gene/glossary/def-item/contiguous-gene-deletion/">contiguous gene deletion</a> of the Williams-Beuren syndrome <a class="def" href="/books/n/gene/glossary/def-item/critical-region/">critical region</a> (WBSCR) that encompasses the elastin gene (<i>ELN</i>).</p></div></dd><dt>4. </dt><dd><div id="gr_22q13_3.TF.3.4"><p class="no_margin">Cardiovascular anomalies in Williams syndrome: elastin arteriopathy, peripheral pulmonary stenosis, supravalvular aortic stenosis, and hypertension.</p></div></dd><dt>5. </dt><dd><div id="gr_22q13_3.TF.3.5"><p class="no_margin">Endocrine abnormalities in Williams syndrome: hypercalcemia, hypercalciuria, hypothyroidism, and early puberty</p></div></dd><dt>6. </dt><dd><div id="gr_22q13_3.TF.3.6"><p class="no_margin">TRPS I is associated with a <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in <i>TRPS1</i>; TRPS II is associated with a contiguous 8q23.3q24.11 <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a> that spans the <i>TRPS1</i>-<i>EXT1</i> interval.</p></div></dd><dt>7. </dt><dd><div id="gr_22q13_3.TF.3.7"><p class="no_margin">SMS is caused by an interstitial <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a> of 17p11.2 or pathogenic variants in <i>RAI1.</i></p></div></dd><dt>8. </dt><dd><div id="gr_22q13_3.TF.3.8"><p class="no_margin">Virtually all occurrences are <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a>.</p></div></dd><dt>9. </dt><dd><div id="gr_22q13_3.TF.3.9"><p class="no_margin">Behavioral abnormalities in SMS: significant sleep disturbance, stereotypies, and maladaptive and self-injurious behaviors.</p></div></dd><dt>10. </dt><dd><div id="gr_22q13_3.TF.3.10"><p class="no_margin"><a class="def" href="/books/n/gene/glossary/def-item/x-linked/">X-linked</a> inheritance is presumed.</p></div></dd></dl></div></div></div><p><b>Cerebral palsy</b> is not a single disorder but a catchall name for a variety of neurologic disorders that are usually present at birth and affect body movements. Because children with Phelan-McDermid syndrome exhibit neonatal hypotonia, poor coordination, and delayed and unsteady walking, a clinician may apply the term "cerebral palsy." The many causes of cerebral palsy include birth trauma, prematurity, low birth weight, infections, intrapartum asphyxia, jaundice, intracranial hemorrhage, and placental abruption. Cerebral palsy can also be caused after birth by asphyxia related to choking, near drowning, poisoning, or other events that reduce the oxygen supply to the brain. Physical injury, including shaken baby syndrome, can also lead to cerebral palsy. Genetic testing that reveals <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a> of 22q13.3 is often the manner in which individuals erroneously diagnosed with cerebral palsy receive the correct diagnosis.</p><p><a href="/books/n/gene/hsp/"><b>Spastic paraplegia</b></a><b>.</b> Because children with Phelan-McDermid syndrome have delayed motor milestones and may walk with an unsteady, "spastic" gait, they may be misdiagnosed as having spastic paraplegia. However, individuals with hereditary spastic paraplegia are distinguished by progressive weakness and spasticity of the lower extremities. Individuals with complex spastic paraplegia may also display neurologic dysfunction including seizures, dementia, and amyotrophy. Spastic paraplegia encompasses a number of neurologic disorders with <a class="def" href="/books/n/gene/glossary/def-item/x-linked/">X-linked</a>, <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a>, or <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> inheritance. Individuals with Phelan-McDermid syndrome do not demonstrate progressive neurologic symptoms characteristic of hereditary spastic paraplegia, yet they may carry this diagnosis until genetic testing that identifies Phelan-McDermid syndrome is performed.</p></div><div id="gr_22q13_3.Management"><h2 id="_gr_22q13_3_Management_">Management</h2><div id="gr_22q13_3.Evaluations_Following_Initial"><h3>Evaluations Following Initial Diagnosis</h3><p>To establish the extent of disease and needs in an individual diagnosed with Phelan-McDermid syndrome, the evaluations summarized in <a class="figpopup" href="/books/NBK1198/table/gr_22q13_3.T.recommended_evaluations_fol/?report=objectonly" target="object" rid-figpopup="figgr22q133Trecommendedevaluationsfol" rid-ob="figobgr22q133Trecommendedevaluationsfol">Table 4</a> (if not performed as part of the evaluation that led to diagnosis) are recommended.</p><div id="gr_22q13_3.T.recommended_evaluations_fol" class="table"><h3><span class="label">Table 4. </span></h3><div class="caption"><p>Recommended Evaluations Following Initial Diagnosis</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1198/table/gr_22q13_3.T.recommended_evaluations_fol/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__gr_22q13_3.T.recommended_evaluations_fol_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_gr_22q13_3.T.recommended_evaluations_fol_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">System/Concern</th><th id="hd_h_gr_22q13_3.T.recommended_evaluations_fol_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">Evaluation</th><th id="hd_h_gr_22q13_3.T.recommended_evaluations_fol_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">Comment</th></tr></thead><tbody><tr><td headers="hd_h_gr_22q13_3.T.recommended_evaluations_fol_1_1_1_1" rowspan="4" scope="row" colspan="1" style="text-align:left;vertical-align:middle;"><b>Neurologic</b></td><td headers="hd_h_gr_22q13_3.T.recommended_evaluations_fol_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Developmental</td><td headers="hd_h_gr_22q13_3.T.recommended_evaluations_fol_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">To assess muscle tone &#x00026; motor, cognitive, social, &#x00026; vocational skills</td></tr><tr><td headers="hd_h_gr_22q13_3.T.recommended_evaluations_fol_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">EEG if seizures are suspected</td><td headers="hd_h_gr_22q13_3.T.recommended_evaluations_fol_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Referral to neurologist for seizure disorder management</td></tr><tr><td headers="hd_h_gr_22q13_3.T.recommended_evaluations_fol_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Brain imaging</td><td headers="hd_h_gr_22q13_3.T.recommended_evaluations_fol_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">In those w/microcephaly, seizures, or symptoms of &#x02191; intracranial pressure from arachnoid cysts</td></tr><tr><td headers="hd_h_gr_22q13_3.T.recommended_evaluations_fol_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Neuropsychological assessment</td><td headers="hd_h_gr_22q13_3.T.recommended_evaluations_fol_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">For behavioral problems &#x00026; evaluation for ASD</td></tr><tr><td headers="hd_h_gr_22q13_3.T.recommended_evaluations_fol_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Speech and language</b></td><td headers="hd_h_gr_22q13_3.T.recommended_evaluations_fol_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Evaluation for communication skills</td><td headers="hd_h_gr_22q13_3.T.recommended_evaluations_fol_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td></tr><tr><td headers="hd_h_gr_22q13_3.T.recommended_evaluations_fol_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Hearing</b></td><td headers="hd_h_gr_22q13_3.T.recommended_evaluations_fol_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Audiology evaluation</td><td headers="hd_h_gr_22q13_3.T.recommended_evaluations_fol_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Especially important in those w/ring <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> 22, who are at risk for NF2</td></tr><tr><td headers="hd_h_gr_22q13_3.T.recommended_evaluations_fol_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Eyes</b></td><td headers="hd_h_gr_22q13_3.T.recommended_evaluations_fol_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Ophthalmology evaluation</td><td headers="hd_h_gr_22q13_3.T.recommended_evaluations_fol_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td></tr><tr><td headers="hd_h_gr_22q13_3.T.recommended_evaluations_fol_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Gastrointestinal</b></td><td headers="hd_h_gr_22q13_3.T.recommended_evaluations_fol_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Feeding and nutrition evaluation</td><td headers="hd_h_gr_22q13_3.T.recommended_evaluations_fol_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;"><ul><li class="half_rhythm"><div>Assess for sucking &#x00026; swallowing difficulties &#x00026; need for feeding therapy in infancy</div></li><li class="half_rhythm"><div>Assess for GER at any age</div></li><li class="half_rhythm"><div>Monitor growth parameters</div></li></ul>
</td></tr><tr><td headers="hd_h_gr_22q13_3.T.recommended_evaluations_fol_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Genitourinary</b></td><td headers="hd_h_gr_22q13_3.T.recommended_evaluations_fol_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;"><ul><li class="half_rhythm"><div>Renal ultrasound</div></li><li class="half_rhythm"><div>Voiding cystourethrogram only if indicated</div></li></ul>
</td><td headers="hd_h_gr_22q13_3.T.recommended_evaluations_fol_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Evaluate for dysplastic kidney, multicystic kidneys, ureteral reflux, &#x00026; other renal problems</td></tr><tr><td headers="hd_h_gr_22q13_3.T.recommended_evaluations_fol_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Endocrine</b></td><td headers="hd_h_gr_22q13_3.T.recommended_evaluations_fol_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Evaluation for hypothyroidism</td><td headers="hd_h_gr_22q13_3.T.recommended_evaluations_fol_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">In those who present w/history of changes in behavior incl lethargy, &#x02193; activity, cognitive regression, &#x00026; loss of coordination</td></tr><tr><td headers="hd_h_gr_22q13_3.T.recommended_evaluations_fol_1_1_1_1" rowspan="4" scope="row" colspan="1" style="text-align:left;vertical-align:middle;"><b>Miscellaneous/</b><br /><b>Other</b></td><td headers="hd_h_gr_22q13_3.T.recommended_evaluations_fol_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Consultation w/clinical geneticist &#x00026;/or genetic counselor</td><td headers="hd_h_gr_22q13_3.T.recommended_evaluations_fol_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td></tr><tr><td headers="hd_h_gr_22q13_3.T.recommended_evaluations_fol_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Sleep study if sleep disturbance present</td><td headers="hd_h_gr_22q13_3.T.recommended_evaluations_fol_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Evaluate for sleep apnea</td></tr><tr><td headers="hd_h_gr_22q13_3.T.recommended_evaluations_fol_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Liver function tests</td><td headers="hd_h_gr_22q13_3.T.recommended_evaluations_fol_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">2 reports of autoimmune hepatitis &#x00026; liver failure [<a class="bk_pop" href="#gr_22q13_3.REF.tufano.2009.225">Tufano et al 2009</a>, <a class="bk_pop" href="#gr_22q13_3.REF.bartsch.2010.2099">Bartsch et al 2010</a>]</td></tr><tr><td headers="hd_h_gr_22q13_3.T.recommended_evaluations_fol_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Cardiac evaluation</td><td headers="hd_h_gr_22q13_3.T.recommended_evaluations_fol_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Detailed cardiac exam w/echo &#x00026; ECG [<a class="bk_pop" href="#gr_22q13_3.REF.kolevzon.2014a.39">Kolevzon et al 2014a</a>]</td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div><p class="no_margin">ASD = autism spectrum disorder; GER = gastroesophageal reflux</p></div></dd></dl></div></div></div></div><div id="gr_22q13_3.Treatment_of_Manifestations"><h3>Treatment of Manifestations</h3><p>Treatment is symptomatic; no specific therapy is available. The following are appropriate interventions.</p><div id="gr_22q13_3.T.treatment_of_manifestations" class="table"><h3><span class="label">Table 5. </span></h3><div class="caption"><p>Treatment of Manifestations in Individuals with Phelan-McDermid Syndrome</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1198/table/gr_22q13_3.T.treatment_of_manifestations/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__gr_22q13_3.T.treatment_of_manifestations_lrgtbl__"><table><thead><tr><th id="hd_h_gr_22q13_3.T.treatment_of_manifestations_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">Manifestation/Concern</th><th id="hd_h_gr_22q13_3.T.treatment_of_manifestations_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">Treatment</th><th id="hd_h_gr_22q13_3.T.treatment_of_manifestations_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">Considerations/Other</th></tr></thead><tbody><tr><td headers="hd_h_gr_22q13_3.T.treatment_of_manifestations_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Developmental delay / Intellectual disability</b></td><td headers="hd_h_gr_22q13_3.T.treatment_of_manifestations_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Early referral for developmental support / special education</td><td headers="hd_h_gr_22q13_3.T.treatment_of_manifestations_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Repetitive, frequent sessions are required; see text following table.</td></tr><tr><td headers="hd_h_gr_22q13_3.T.treatment_of_manifestations_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Speech &#x00026; language</b></td><td headers="hd_h_gr_22q13_3.T.treatment_of_manifestations_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Assistive technology (e.g., touch screen, icons, photographs) may advance communication.</td><td headers="hd_h_gr_22q13_3.T.treatment_of_manifestations_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td></tr><tr><td headers="hd_h_gr_22q13_3.T.treatment_of_manifestations_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Seizures</b></td><td headers="hd_h_gr_22q13_3.T.treatment_of_manifestations_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Treatment per neurologist based on type of seizure present</td><td headers="hd_h_gr_22q13_3.T.treatment_of_manifestations_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Counsel parents &#x00026; caregivers to recognize absence seizures.</td></tr><tr><td headers="hd_h_gr_22q13_3.T.treatment_of_manifestations_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Hearing loss</b></td><td headers="hd_h_gr_22q13_3.T.treatment_of_manifestations_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Consideration of amplification</td><td headers="hd_h_gr_22q13_3.T.treatment_of_manifestations_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td></tr><tr><td headers="hd_h_gr_22q13_3.T.treatment_of_manifestations_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Recurrent ear infections</b></td><td headers="hd_h_gr_22q13_3.T.treatment_of_manifestations_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Tympanostomy tubes</td><td headers="hd_h_gr_22q13_3.T.treatment_of_manifestations_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td></tr><tr><td headers="hd_h_gr_22q13_3.T.treatment_of_manifestations_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Vision issues / Strabismus</b></td><td headers="hd_h_gr_22q13_3.T.treatment_of_manifestations_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Standard management for visual problems as directed by ophthalmologist</td><td headers="hd_h_gr_22q13_3.T.treatment_of_manifestations_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td></tr><tr><td headers="hd_h_gr_22q13_3.T.treatment_of_manifestations_1_1_1_1" rowspan="3" scope="row" colspan="1" style="text-align:left;vertical-align:middle;"><b>Feeding issues</b></td><td headers="hd_h_gr_22q13_3.T.treatment_of_manifestations_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Oral-motor therapy to alleviate chewing &#x00026; swallowing problems</td><td headers="hd_h_gr_22q13_3.T.treatment_of_manifestations_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td></tr><tr><td headers="hd_h_gr_22q13_3.T.treatment_of_manifestations_1_1_1_2" colspan="1" scope="col" rowspan="1" style="text-align:left;vertical-align:middle;">Standard therapy for GER</td><td headers="hd_h_gr_22q13_3.T.treatment_of_manifestations_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td></tr><tr><td headers="hd_h_gr_22q13_3.T.treatment_of_manifestations_1_1_1_2" colspan="1" scope="col" rowspan="1" style="text-align:left;vertical-align:middle;">Monitor growth parameters.</td><td headers="hd_h_gr_22q13_3.T.treatment_of_manifestations_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td></tr><tr><td headers="hd_h_gr_22q13_3.T.treatment_of_manifestations_1_1_1_1" rowspan="2" scope="row" colspan="1" style="text-align:left;vertical-align:middle;"><b>Dental</b></td><td headers="hd_h_gr_22q13_3.T.treatment_of_manifestations_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Regular professional dental hygiene, routine brushing, &#x00026; fluoride treatment</td><td headers="hd_h_gr_22q13_3.T.treatment_of_manifestations_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Enamel may be damaged by persistent chewing.</td></tr><tr><td headers="hd_h_gr_22q13_3.T.treatment_of_manifestations_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Consultation w/pediatric orthodontist</td><td headers="hd_h_gr_22q13_3.T.treatment_of_manifestations_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Regarding malocclusion &#x00026; need for orthodontic intervention</td></tr><tr><td headers="hd_h_gr_22q13_3.T.treatment_of_manifestations_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Hypothyroidism</b></td><td headers="hd_h_gr_22q13_3.T.treatment_of_manifestations_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Thyroid hormone replacement therapy as needed</td><td headers="hd_h_gr_22q13_3.T.treatment_of_manifestations_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td></tr><tr><td headers="hd_h_gr_22q13_3.T.treatment_of_manifestations_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Sleep disturbance</b></td><td headers="hd_h_gr_22q13_3.T.treatment_of_manifestations_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Sleep hygiene healthy habits &#x00026; potential medical management as needed</td><td headers="hd_h_gr_22q13_3.T.treatment_of_manifestations_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Parents may keep a sleep diary to document sleep habits.</td></tr><tr><td headers="hd_h_gr_22q13_3.T.treatment_of_manifestations_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Lymphedema</b></td><td headers="hd_h_gr_22q13_3.T.treatment_of_manifestations_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Use of pressure stockings &#x00026; elevation of the foot of the bed</td><td headers="hd_h_gr_22q13_3.T.treatment_of_manifestations_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">If severe, may require peristaltic pressure to push fluid from foot toward the body</td></tr><tr><td headers="hd_h_gr_22q13_3.T.treatment_of_manifestations_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Cardiac</b></td><td headers="hd_h_gr_22q13_3.T.treatment_of_manifestations_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Standard management for any identified cardiac issues</td><td headers="hd_h_gr_22q13_3.T.treatment_of_manifestations_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Monitor blood pressure.</td></tr></tbody></table></div></div><div id="gr_22q13_3.Developmental_Delay__Intellec"><h4>Developmental Delay / Intellectual Disability Management Issues</h4><p>The following information represents typical management recommendations for individuals with developmental delay / intellectual disability in the United States; standard recommendations may vary from country to country.</p><p><b>Ages 0-3 years.</b> Referral to an early intervention program is recommended for access to occupational, physical, speech, and feeding therapy. In the US, early intervention is a federally funded program available in all states.</p><p><b>Ages 3-5 years.</b> In the US, developmental preschool through the local public school district is recommended. Before placement, an evaluation is made to determine needed services and therapies and an individualized education plan (IEP) is developed.</p><p><b>Ages 5-21 years</b></p><ul><li class="half_rhythm"><div>In the US, an IEP based on the individual's level of function should be developed by the local public school district. Affected children are permitted to remain in the public school district until age 21.</div></li><li class="half_rhythm"><div>Discussion about transition plans including financial, vocation/employment, and medical arrangements should begin at age 12 years. Developmental pediatricians can provide assistance with transition to adulthood.</div></li></ul><p><b>All ages.</b> Consultation with a developmental pediatrician is recommended to ensure the involvement of appropriate community, state, and educational agencies and to support parents in maximizing quality of life.</p><p>Consideration of private supportive therapies based on the <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual's needs is recommended. Specific recommendations regarding type of therapy can be made by a developmental pediatrician.</p><p>In the US:</p><ul><li class="half_rhythm"><div>Developmental Disabilities Administration (DDA) enrollment is recommended. DDA is a public agency that provides services and support to qualified individuals. Eligibility differs by state but is typically determined by diagnosis and/or associated cognitive/adaptive disabilities.</div></li><li class="half_rhythm"><div>Families with limited income and resources may also qualify for supplemental security income (SSI) for their child with a disability.</div></li></ul></div><div id="gr_22q13_3.Motor_Dysfunction"><h4>Motor Dysfunction</h4><p><b>Gross motor dysfunction</b></p><ul><li class="half_rhythm"><div>Physical therapy is recommended to maximize mobility and to reduce the risk for later-onset orthopedic complications (e.g., scoliosis, hip dislocation).</div></li><li class="half_rhythm"><div>Consider use of durable medical equipment as needed (e.g., wheelchairs, walkers, bath chairs, orthotics, adaptive strollers).</div></li></ul><p><b>Fine motor dysfunction.</b> Occupational therapy is recommended for difficulty with fine motor skills that affect adaptive function such as feeding, grooming, dressing, and writing.</p><p><b>Oral motor dysfunction.</b> Assuming that the individual is safe to eat by mouth, feeding therapy &#x02013; typically from an occupational or speech therapist &#x02013; is recommended for <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals who have difficulty feeding due to poor oral motor control.</p><p><b>Communication issues.</b> Consider evaluation for alternative means of communication (e.g., <a href="http://www.asha.org/NJC/AAC/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Augmentative and Alternative Communication</a> [AAC]) for individuals who have expressive language difficulties.</p></div><div id="gr_22q13_3.SocialBehavioral_Concerns"><h4>Social/Behavioral Concerns</h4><p>Children may qualify for and benefit from interventions used in treatment of autism spectrum disorder, including applied behavior analysis (ABA). ABA therapy is targeted to the individual child's behavioral, social, and adaptive strengths and weaknesses and is typically performed one-on-one with a board-certified behavior analyst.</p><p>Consultation with a developmental pediatrician may be helpful in guiding parents through appropriate behavior management strategies or providing prescription medications when necessary.</p></div></div><div id="gr_22q13_3.Surveillance"><h3>Surveillance</h3><div id="gr_22q13_3.T.recommended_surveillance_fo" class="table"><h3><span class="label">Table 6. </span></h3><div class="caption"><p>Recommended Surveillance for Individuals with Phelan-McDermid Syndrome</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1198/table/gr_22q13_3.T.recommended_surveillance_fo/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__gr_22q13_3.T.recommended_surveillance_fo_lrgtbl__"><table><thead><tr><th id="hd_h_gr_22q13_3.T.recommended_surveillance_fo_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">System/Concern</th><th id="hd_h_gr_22q13_3.T.recommended_surveillance_fo_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">Evaluation</th><th id="hd_h_gr_22q13_3.T.recommended_surveillance_fo_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">Frequency/Comment</th></tr></thead><tbody><tr><td headers="hd_h_gr_22q13_3.T.recommended_surveillance_fo_1_1_1_1" rowspan="2" scope="row" colspan="1" style="text-align:left;vertical-align:middle;"><b>Neurologic</b></td><td headers="hd_h_gr_22q13_3.T.recommended_surveillance_fo_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Developmental assessments</td><td headers="hd_h_gr_22q13_3.T.recommended_surveillance_fo_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">At regular intervals to adjust therapies &#x00026; adapt educational needs</td></tr><tr><td headers="hd_h_gr_22q13_3.T.recommended_surveillance_fo_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">By a neurologist for epilepsy, changes in behavior, or regression in skills</td><td headers="hd_h_gr_22q13_3.T.recommended_surveillance_fo_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">As determined by neurologist</td></tr><tr><td headers="hd_h_gr_22q13_3.T.recommended_surveillance_fo_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Ocular</b></td><td headers="hd_h_gr_22q13_3.T.recommended_surveillance_fo_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Ophthalmology to screen for refractive errors &#x00026; strabismus</td><td headers="hd_h_gr_22q13_3.T.recommended_surveillance_fo_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">At regular intervals</td></tr><tr><td headers="hd_h_gr_22q13_3.T.recommended_surveillance_fo_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Dental</b></td><td headers="hd_h_gr_22q13_3.T.recommended_surveillance_fo_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Tooth decay, malocclusion, crowding</td><td headers="hd_h_gr_22q13_3.T.recommended_surveillance_fo_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">At regular intervals</td></tr><tr><td headers="hd_h_gr_22q13_3.T.recommended_surveillance_fo_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Musculoskeletal</b></td><td headers="hd_h_gr_22q13_3.T.recommended_surveillance_fo_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Monitor for lymphedema</td><td headers="hd_h_gr_22q13_3.T.recommended_surveillance_fo_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Teen &#x00026; adult years</td></tr></tbody></table></div></div><p>Note: It is not intuitive that individuals with a <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a> of <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> 22q13 would be at risk for NF2, but those with a ring chromosome are at significant risk.</p><ul><li class="half_rhythm"><div>If the diagnosis of Phelan-McDermid syndrome associated with a <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a> of <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> 22q13 was made by <a class="def" href="/books/n/gene/glossary/def-item/chromosomal-microarray/">chromosomal microarray</a> analysis (CMA), a follow-up <a class="def" href="/books/n/gene/glossary/def-item/karyotype/">karyotype</a> is necessary to see if a ring chromosome is present.</div></li><li class="half_rhythm"><div>If a ring <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> is present, the individual should have a baseline ocular, dermal, and neurologic examination.</div></li><li class="half_rhythm"><div>Between ages two and ten years, annual ocular, dermal, and neurologic exams should be performed.</div></li><li class="half_rhythm"><div>After age ten years, additional audiologic screening should be performed annually and a brain MRI performed every two years.</div></li></ul></div><div id="gr_22q13_3.AgentsCircumstances_to_Avoid"><h3>Agents/Circumstances to Avoid</h3><p>Exposure to high temperatures and extended periods in the sun should be avoided because individuals with Phelan-McDermid syndrome have reduced perspiration and tend to overheat easily.</p><p>Considering that individuals with Phelan-McDermid syndrome may present with decreased perception of pain, close surveillance is recommended to prevent exposure to dangers including sources of excessive heat or cold, sharp objects, or clothes/shoes that may be too tight and cause skin lesions.</p></div><div id="gr_22q13_3.Evaluation_of_Relatives_at_Ri"><h3>Evaluation of Relatives at Risk</h3><p>See <a href="#gr_22q13_3.Related_Genetic_Counseling_Is">Genetic Counseling</a> for issues related to testing of at-risk relatives for <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a> purposes.</p></div><div id="gr_22q13_3.Therapies_Under_Investigation"><h3>Therapies Under Investigation</h3><p><b>Lithium.</b> Lithium has been used to treat behavioral issues in three <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals. First, <a class="bk_pop" href="#gr_22q13_3.REF.serret.2015.107">Serret et al [2015]</a> reported two adolescents with Phelan-McDermid syndrome and ASD resulting from pathogenic variants in <i>SHANK3.</i> The individuals presented with catatonia, regression, and behavioral issues after stressful events. Lithium reversed the regression and improved the behavioral issues, and the individuals returned to their pre-catatonia level of functioning. <a class="bk_pop" href="#gr_22q13_3.REF.egger.2017">Egger et al [2017]</a> described an adult with a <i>SHANK3</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> who had an atypical bipolar mood disorder that was stabilized by lithium treatment.</p><p><b>IGF-1.</b> Insulin-like growth factor-1 (IGF-1) was investigated in a placebo-controlled, double-blind, crossover study involving nine children with Phelan-McDermid syndrome [<a class="bk_pop" href="#gr_22q13_3.REF.kolevzon.2014b.54">Kolevzon et al 2014b</a>]. Results indicated a significant improvement in social impairment and in restrictive behavior during the IGF-1 phase compared to the placebo phase. Nonetheless, this was a very small study and larger studies are required to confirm the validity of IGF-1 therapy.</p><p>Search <a href="http://clinicaltrials.gov/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">ClinicalTrials.gov</a> in the US and <a href="http://www.clinicaltrialsregister.eu/ctr-search/search" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">EU Clinical Trials Register</a> in Europe for information on clinical studies for a wide range of diseases and conditions.</p></div></div><div id="gr_22q13_3.Genetic_Counseling"><h2 id="_gr_22q13_3_Genetic_Counseling_">Genetic Counseling</h2><p>
<i>Genetic counseling is the process of providing individuals and families with
information on the nature, inheritance, and implications of genetic disorders to help them
make informed medical and personal decisions. The following section deals with genetic
risk assessment and the use of family history and genetic testing to clarify genetic
status for family members. This section is not meant to address all personal, cultural, or
ethical issues that individuals may face or to substitute for consultation with a genetics
professional</i>. &#x02014;ED.</p><div id="gr_22q13_3.Mode_of_Inheritance"><h3>Mode of Inheritance</h3><p>Phelan-McDermid syndrome, caused by a <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a> at <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> 22q13.3 that includes at least part of <i>SHANK3</i> or, more rarely, an intragenic <i>SHANK3</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>, is inherited in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> manner; however, the majority of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals represent <a class="def" href="/books/n/gene/glossary/def-item/simplex/">simplex</a> cases (i.e., a single affected family member).</p></div><div id="gr_22q13_3.Risk_to_Family_Members"><h3>Risk to Family Members</h3><div id="gr_22q13_3.22q13_3_Deletion"><h4>22q13.3 Deletion</h4><p>Most terminal or interstitial deletions of 22q13.3 are <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> in the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>; however, the <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a> may be the result of a <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> rearrangement or <a class="def" href="/books/n/gene/glossary/def-item/mosaicism/">mosaicism</a> in a parent.</p><p><b>Parents of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div>Evaluation of the parents by <a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> testing that will detect the 22q13.3 <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a> present in the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> is recommended. Testing for a balanced <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> rearrangement in the parents is also recommended.</div></li><li class="half_rhythm"><div>In rare cases, a parent may be found to have a 22q13.3 <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a>; mild expression of Phelan-McDermid syndrome was described in the mother of a child who carried a maternally inherited deletion [<a class="bk_pop" href="#gr_22q13_3.REF.wilson.2008.1301">Wilson et al 2008</a>].</div></li><li class="half_rhythm"><div>Approximately 50% of unbalanced structural rearrangements that include 22q13 (e.g., reciprocal translocations, insertional translocations, inversions) are <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> and approximately 50% are inherited from a parent who is a <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a> for a balanced <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> rearrangement.</div></li><li class="half_rhythm"><div>Although the probability of parental <a class="def" href="/books/n/gene/glossary/def-item/mosaicism/">mosaicism</a> for 22q13.3 <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a> is low, it is important that parental mosaicism be considered when parental studies are performed. See <a href="#gr_22q13_3.Clinical_Description">Clinical Description</a>, <b>Mosaic deletion 22q13.3</b>.</div></li></ul><p><b>Sibs of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>.</b> The risk to sibs of a proband with a 22q13.3 <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a> depends on the <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> findings in the parents:</p><ul><li class="half_rhythm"><div>If one of the parents has the 22q13.3 <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a>, the risk to each sib of inheriting the deletion is 50%. However, it is not possible to reliably predict the <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> of the individual.</div></li><li class="half_rhythm"><div>If one of the parents has a balanced <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> rearrangement, the risk to sibs of having a 22q13.3 <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a> is increased and depends on the specific chromosome rearrangement and the possibility of other variables.</div></li><li class="half_rhythm"><div>If the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> represents a <a class="def" href="/books/n/gene/glossary/def-item/simplex/">simplex</a> case and neither parent has the 22q13.3 <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a> identified in the proband or a balanced <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> rearrangement, the <a class="def" href="/books/n/gene/glossary/def-item/recurrence-risk/">recurrence risk</a> to sibs of Phelan-McDermid syndrome is empirically assessed at approximately 1%.</div></li></ul><p><b>Offspring of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>.</b> Offspring of an individual with a 22q13.3 <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a> have a 50% chance of inheriting the deletion [<a class="bk_pop" href="#gr_22q13_3.REF.terrone.2017.902">Terrone et al 2017</a>].</p><p><b>Other family members.</b> The risk to other family members depends on the genetic status of the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>'s parents: if a parent has a balanced <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> rearrangement or <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a>, his or her family members may be at risk and should be offered chromosome analysis and/or <a class="def" href="/books/n/gene/glossary/def-item/fish/">FISH</a>.</p></div><div id="gr_22q13_3.SHANK3_Pathogenic_Variant"><h4><i>SHANK3</i> Pathogenic Variant</h4><p><b>Parents of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div>In most individuals with Phelan-McDermid syndrome resulting from an intragenic <i>SHANK3</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>, the <i>SHANK3</i> pathogenic variant is <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a>.</div></li><li class="half_rhythm"><div>Molecular genetic testing is recommended for the parents of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> with an apparent <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>.</div></li><li class="half_rhythm"><div>If the <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> found in the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> cannot be detected in the leukocyte DNA of either parent, the proband most likely has a <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> pathogenic variant; another possible explanation is <a class="def" href="/books/n/gene/glossary/def-item/germline-mosaicism/">germline mosaicism</a> in a parent. While theoretically possible, germline mosaicism has not been reported.</div></li></ul><p><b>Sibs of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>.</b> The risk to the sibs of the proband depends on the clinical/genetic status of the proband's parents:</p><ul><li class="half_rhythm"><div>If a parent of the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> is <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> or known to have an intragenic <i>SHANK3</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>, the risk to the sibs is 50%; intrafamilial clinical variability has been reported [<a class="bk_pop" href="#gr_22q13_3.REF.tabet.2017.32">Tabet et al 2017</a>]).</div></li><li class="half_rhythm"><div>If the <i>SHANK3</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> found in the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> cannot be detected in the leukocyte DNA of either parent, the <a class="def" href="/books/n/gene/glossary/def-item/recurrence-risk/">recurrence risk</a> to sibs is estimated at 1% because of the theoretic possibility of parental <a class="def" href="/books/n/gene/glossary/def-item/germline-mosaicism/">germline mosaicism</a> [<a class="bk_pop" href="#gr_22q13_3.REF.rahbari.2016.126">Rahbari et al 2016</a>].</div></li><li class="half_rhythm"><div>If the parents have not been tested for the <i>SHANK3</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> but are clinically unaffected, the risk to the sibs of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> of having Phelan-McDermid syndrome appears to be low. However, the sibs of a proband with clinically unaffected parents are still at increased risk for inheriting the <i>SHANK3</i> pathogenic variant because of the theoretic possibility of parental <a class="def" href="/books/n/gene/glossary/def-item/germline-mosaicism/">germline mosaicism</a> and the possibility of non-<a class="def" href="/books/n/gene/glossary/def-item/penetrance/">penetrance</a> and/or <a class="def" href="/books/n/gene/glossary/def-item/variable-expressivity/">variable expressivity</a> in a <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> parent [<a class="bk_pop" href="#gr_22q13_3.REF.tabet.2017.32">Tabet et al 2017</a>].</div></li></ul><p><b>Offspring of a</b>
<b><a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>.</b> Individuals with a <i>SHANK3</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> have a 50% chance of transmitting the pathogenic variant to each child.</p></div></div><div id="gr_22q13_3.Related_Genetic_Counseling_Is"><h3>Related Genetic Counseling Issues</h3><p><b>Family planning</b></p><ul><li class="half_rhythm"><div>The optimal time for determination of genetic risk, clarification of <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a> status, and discussion of the availability of prenatal testing is before pregnancy.</div></li><li class="half_rhythm"><div>It is appropriate to offer <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a> (including discussion of potential risks to offspring and reproductive options) to young adults who are at risk of having a child with Phelan-McDermid syndrome. Note: If a parent is known to have a balanced <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> rearrangement, genetic counseling should also address reproductive risks associated with balanced chromosome rearrangements.</div></li></ul><p><b>DNA banking</b> is the storage of DNA (typically extracted from white blood cells) for possible future use. Because it is likely that testing methodology and our understanding of genes, <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> variants, and diseases will improve in the future, consideration should be given to banking DNA of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals.</p></div><div id="gr_22q13_3.Prenatal_Testing_and_Preimpla"><h3>Prenatal Testing and Preimplantation Genetic Diagnosis</h3><p><b>Pregnancies known to be at increased risk for Phelan-McDermid syndrome.</b> Once a <i>SHANK3</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> or a 22q13.3 <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a> has been identified in an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> family member, prenatal testing for a pregnancy at increased risk and <a class="def" href="/books/n/gene/glossary/def-item/preimplantation-genetic-diagnosis/">preimplantation genetic diagnosis</a> are possible.</p><p>Prenatal testing to detect the <i>SHANK3</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> identified in the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> or CMA that will detect the 22q13.3 <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a> found in the proband may be offered in the following instances:</p><ul><li class="half_rhythm"><div>The parents do not have a <i>SHANK3</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>, 22q13.3 <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a>, or balanced <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> rearrangement but have had an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> child. In this instance, the <a class="def" href="/books/n/gene/glossary/def-item/recurrence-risk/">recurrence risk</a> associated with the possibility of parental <a class="def" href="/books/n/gene/glossary/def-item/germline-mosaicism/">germline mosaicism</a> or other predisposing genetic mechanisms is approximately 1%.</div></li><li class="half_rhythm"><div>A parent has a balanced <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> rearrangement that resulted in a previous child with a 22q13.3 <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a>. Note: In most cases, the unbalanced rearrangement can be detected by CMA and this is the appropriate test to offer. In some cases, the parents may be concerned about producing a child with a balanced <a class="def" href="/books/n/gene/glossary/def-item/karyotype/">karyotype</a> that would not be detected by CMA but would be seen by chromosome analysis and <a class="def" href="/books/n/gene/glossary/def-item/fish/">FISH</a>. In all cases, <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a> is necessary to determine the priorities of the parents.</div></li></ul><p>Both mosaic and non-mosaic deletions of 22q13.3 have been successfully identified prenatally [<a class="bk_pop" href="#gr_22q13_3.REF.riegel.2000.76">Riegel et al 2000</a>, <a class="bk_pop" href="#gr_22q13_3.REF.phelan.2001.1100">Phelan 2001</a>, <a class="bk_pop" href="#gr_22q13_3.REF.maitz.2008.978">Maitz et al 2008</a>, <a class="bk_pop" href="#gr_22q13_3.REF.ko_.2009.978">Ko&#x000e7; et al 2009</a>].</p><p>Differences in perspective may exist among medical professionals and within families regarding the use of prenatal testing, particularly if the testing is being considered for the purpose of pregnancy termination rather than early diagnosis. While most centers would consider decisions regarding prenatal testing to be the choice of the parents, discussion of these issues is appropriate.</p><p><b>Pregnancies not known to be at increased risk for Phelan-McDermid syndrome.</b> CMA performed in a pregnancy not known to be at increased risk may detect a 22q13.3 <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a>.</p><p>Note: Regardless of whether a pregnancy is known or not known to be at increased risk for 22q13.3 <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a>, prenatal test results cannot reliably predict the <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a>.</p></div></div><div id="gr_22q13_3.Resources"><h2 id="_gr_22q13_3_Resources_">Resources</h2><p>
<i>GeneReviews staff has selected the following disease-specific and/or umbrella
support organizations and/or registries for the benefit of individuals with this disorder
and their families. GeneReviews is not responsible for the information provided by other
organizations. For information on selection criteria, click <a href="/books/n/gene/app4/">here</a>.</i></p><ul><li class="half_rhythm"><div><b>Phelan-McDermid Syndrome Foundation</b></div><div>8 Sorrento Drive</div><div>PO Box 1153</div><div>Osprey FL 34229</div><div><b>Phone:</b> 941-485-8000</div><div><b>Email:</b> info@pmsf.org</div><div><a href="https://www.pmsf.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.pmsf.org</a></div></li><li class="half_rhythm"><div><b>Chromosome 22 Central</b></div><div>c/o Murney Rinholm</div><div>7108 Partinwood Drive</div><div>Fuquay-Varina NC 27526</div><div><b>Phone:</b> 919-567-8167</div><div><b>Email:</b> usinfo@c22c.org</div><div><a href="http://www.c22c.org" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.c22c.org</a></div></li><li class="half_rhythm"><div><b>Chromosome Disorder Outreach (CDO)</b></div><div>PO Box 724</div><div>Boca Raton FL 33429-0724</div><div><b>Phone:</b> 561-395-4252 (Family Helpline)</div><div><b>Email:</b> info@chromodisorder.org</div><div><a href="http://www.chromodisorder.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.chromodisorder.org</a></div></li><li class="half_rhythm"><div><b>Unique: The Rare Chromosome Disorder Support Group</b></div><div>G1 The Stables</div><div>Station Road West</div><div>Oxted Surrey RH8 9EE</div><div>United Kingdom</div><div><b>Phone:</b> +44 (0) 1883 723356</div><div><b>Email:</b> info@rarechromo.org; rarechromo@aol.com</div><div><a href="http://www.rarechromo.org" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.rarechromo.org</a></div></li></ul></div><div id="gr_22q13_3.Molecular_Genetics"><h2 id="_gr_22q13_3_Molecular_Genetics_">Molecular Genetics</h2><p><i>Information in the Molecular Genetics and OMIM tables may differ from that elsewhere in the GeneReview: tables may contain more recent information. &#x02014;</i>ED.</p><div id="gr_22q13_3.molgen.TA" class="table"><h3><span class="label">Table A.</span></h3><div class="caption"><p>Phelan-McDermid Syndrome: Genes and Databases</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1198/table/gr_22q13_3.molgen.TA/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__gr_22q13_3.molgen.TA_lrgtbl__"><table class="no_bottom_margin"><tbody><tr><th id="hd_b_gr_22q13_3.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;">Gene</th><th id="hd_b_gr_22q13_3.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;">Chromosome Locus</th><th id="hd_b_gr_22q13_3.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;">Protein</th><th id="hd_b_gr_22q13_3.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;">Locus-Specific Databases</th><th id="hd_b_gr_22q13_3.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;">HGMD</th><th id="hd_b_gr_22q13_3.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;">ClinVar</th></tr><tr><td headers="hd_b_gr_22q13_3.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;"><i>Not applicable</i></td><td headers="hd_b_gr_22q13_3.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;">22q13.3</td><td headers="hd_b_gr_22q13_3.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;">Not applicable</td><td headers="hd_b_gr_22q13_3.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;"></td><td headers="hd_b_gr_22q13_3.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;"></td><td headers="hd_b_gr_22q13_3.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;"></td></tr><tr><td headers="hd_b_gr_22q13_3.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;"><a href="/gene/85358" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=gene"><i>SHANK3</i></a></td><td headers="hd_b_gr_22q13_3.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/genome/gdv/?context=gene&#x00026;acc=85358" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">22q13<wbr style="display:inline-block"></wbr>​.33</a></td><td headers="hd_b_gr_22q13_3.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.uniprot.org/uniprot/Q9BYB0" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">SH3 and multiple ankyrin repeat domains protein 3</a></td><td headers="hd_b_gr_22q13_3.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://databases.lovd.nl/shared/genes/SHANK3" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">SHANK3 @ LOVD</a></td><td headers="hd_b_gr_22q13_3.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.hgmd.cf.ac.uk/ac/gene.php?gene=SHANK3" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">SHANK3</a></td><td headers="hd_b_gr_22q13_3.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/clinvar/?term=SHANK3[gene]" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">SHANK3</a></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div id="gr_22q13_3.TFA.1"><p class="no_margin">Data are compiled from the following standard references: <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> from
<a href="http://www.genenames.org/index.html" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">HGNC</a>;
<a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a> from
<a href="http://www.omim.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">OMIM</a>;
protein from <a href="http://www.uniprot.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">UniProt</a>.
For a description of databases (Locus Specific, HGMD, ClinVar) to which links are provided, click
<a href="/books/n/gene/app1/">here</a>.</p></div></dd></dl></div></div></div><div id="gr_22q13_3.molgen.TB" class="table"><h3><span class="label">Table B.</span></h3><div class="caption"><p>OMIM Entries for Phelan-McDermid Syndrome (<a href="/omim/606230,606232" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">View All in OMIM</a>) </p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1198/table/gr_22q13_3.molgen.TB/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__gr_22q13_3.molgen.TB_lrgtbl__"><table><tbody><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/606230" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">606230</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">SH3 AND MULTIPLE ANKYRIN REPEAT DOMAINS 3; SHANK3</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/606232" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">606232</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">PHELAN-MCDERMID SYNDROME; PHMDS</td></tr></tbody></table></div></div><div id="gr_22q13_3.Molecular_Pathogenesis"><h3>Molecular Pathogenesis</h3><p>The size of the 22q13.3 <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a> in Phelan-McDermid syndrome ranges from &#x0003c;50 kb to &#x0003e;9 Mb.</p><p>The majority of terminal deletions of 22q13.3 (69%-74%) occur on the paternal <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> 22 [<a class="bk_pop" href="#gr_22q13_3.REF.luciani.2003.690">Luciani et al 2003</a>, <a class="bk_pop" href="#gr_22q13_3.REF.wilson.2003.575">Wilson et al 2003</a>].</p><p>The <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> included in the <a class="def" href="/books/n/gene/glossary/def-item/critical-region/">critical region</a> is <i>SHANK3</i>, near the q-terminus on <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> 22. <i>SHANK3</i> (previously known as <i>PROSAP2</i>) is completely or partially deleted in virtually all cases; rarely, it is disrupted by an apparently balanced <a class="def" href="/books/n/gene/glossary/def-item/translocation/">translocation</a> [<a class="bk_pop" href="#gr_22q13_3.REF.bonaglia.2001.261">Bonaglia et al 2001</a>].</p><p>Molecular characterization of terminal deletions in three unrelated individuals with Phelan-McDermid syndrome identified the same 15-<a class="def" href="/books/n/gene/glossary/def-item/base-pair/">base pair</a> repeat unit in the D22S167 sequence variant between exons 8 and 9 as a recurrent breakpoint [<a class="bk_pop" href="#gr_22q13_3.REF.wong.1997.113">Wong et al 1997</a>, <a class="bk_pop" href="#gr_22q13_3.REF.anderlid.2002.439">Anderlid et al 2002</a>, <a class="bk_pop" href="#gr_22q13_3.REF.bonaglia.2006.822">Bonaglia et al 2006</a>].</p><p>Heterozygous inactivation of <i>SHANK3</i> is responsible for the majority of neurologic features of Phelan-McDermid syndrome [<a class="bk_pop" href="#gr_22q13_3.REF.wilson.2003.575">Wilson et al 2003</a>]. Analysis of <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a> breakpoints in <i>SHANK3</i> suggests the presence of a deletion <a class="def" href="/books/n/gene/glossary/def-item/hot-spot/">hot spot</a> [<a class="bk_pop" href="#gr_22q13_3.REF.bonaglia.2006.822">Bonaglia et al 2006</a>].</p><p>Evidence for a role for <i>SHANK3</i> in Phelan-McDermid syndrome:</p><ul><li class="half_rhythm"><div><a class="bk_pop" href="#gr_22q13_3.REF.bonaglia.2001.261">Bonaglia et al [2001]</a> reported a child with a <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> balanced <a class="def" href="/books/n/gene/glossary/def-item/translocation/">translocation</a> t(12;22) (q24.1;q13.3) that disrupted <i>SHANK3</i>.</div></li><li class="half_rhythm"><div><a class="bk_pop" href="#gr_22q13_3.REF.anderlid.2002.439">Anderlid et al [2002]</a> described the disruption of <i>SHANK3</i> resulting from a 100-kb <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a> in an individual with the Phelan-McDermid syndrome <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a>.</div></li><li class="half_rhythm"><div>In a study of two unrelated individuals with 100-kb deletions of 22q13, one of whom was the individual described by <a class="bk_pop" href="#gr_22q13_3.REF.anderlid.2002.439">Anderlid et al [2002]</a>, <a class="bk_pop" href="#gr_22q13_3.REF.bonaglia.2006.822">Bonaglia et al [2006]</a> concluded that the direct repeat within <i>SHANK3</i> may form slipped (hairpin) structures with a strong potential for forming tetraplexes, suggesting a possible mechanism for the occurrence of a common breakpoint.</div></li><li class="half_rhythm"><div>Two studies, one involving 56 individuals with 22q13.3 <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a> [<a class="bk_pop" href="#gr_22q13_3.REF.wilson.2003.575">Wilson et al 2003</a>] and the other 32 individuals [<a class="bk_pop" href="#gr_22q13_3.REF.luciani.2003.690">Luciani et al 2003</a>], proposed <i>SHANK3</i> as a candidate <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> for the neurologic deficits of Phelan-McDermid syndrome (developmental delay and impaired speech) because it is located in the <a class="def" href="/books/n/gene/glossary/def-item/critical-region/">critical region</a>, is preferentially expressed in the cerebral cortex and the cerebellum, and encodes a protein in the postsynaptic density (PSD) of the excitatory synapses.</div></li><li class="half_rhythm"><div>Thirty-four of 35 individuals in a study of ring 22 were <a class="def" href="/books/n/gene/glossary/def-item/hemizygous/">hemizygous</a> for <i>SHANK3</i> and demonstrated typical features of Phelan-McDermid syndrome including moderate to profound developmental delay, absent or delayed speech, autistic traits, and variable <a class="def" href="/books/n/gene/glossary/def-item/dysmorphic/">dysmorphic</a> features. The single individual whose ring <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> did not disrupt <i>SHANK3</i> was a phenotypically normal female. This study lends further credence to the role of <i>SHANK3</i> in normal neurologic development and supports the observation that hemizygosity for <i>SHANK3</i> leads to intellectual disability, language deficits, and atypical behavior [<a class="bk_pop" href="#gr_22q13_3.REF.jeffries.2005.139">Jeffries et al 2005</a>].</div></li></ul><p>Boccuto [personal observation] examined <i>SHANK3</i> in 44 individuals with clinical features of Phelan-McDermid syndrome but with no apparent <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a> of <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> 22 by CMA, subtelomere <a class="def" href="/books/n/gene/glossary/def-item/fish/">FISH</a>, or MPLA. Two <a class="def" href="/books/n/gene/glossary/def-item/loss-of-function/">loss-of-function</a> variants were identified: c.3931delG (p.Glu1311fs) and a partial-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> deletion (detected by customized FISH using cosmids n66c4 and n85a3).</p><p>Together these data provide compelling evidence that <i>SHANK3</i> is the <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> responsible for at least the developmental delay and speech deficit associated with Phelan-McDermid syndrome. The contribution of epigenetic factors to the phenotypic expression in Phelan-McDermid syndrome is yet unknown.</p><p>In addition to <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a>/disruption of <i>SHANK3</i>, deletion/disruption of other nearby genes as a cause of Phelan-McDermid syndrome seems possible. <i>MAPK8IP2</i> is approximately 70 kb proximal to <i>SHANK3</i> and is deleted in the majority of individuals with Phelan-McDermid syndrome [<a class="bk_pop" href="#gr_22q13_3.REF.giza.2010.14805">Giza et al 2010</a>]. Experiments in mice demonstrate that <i>Mapk8ip2</i> is highly expressed in the brain and is an essential component of the postsynaptic density. Mice lacking <i>Mapk8ip2</i> demonstrate cognitive deficits reminiscent of those in individuals with deletion of 22q13.</p><p><a class="bk_pop" href="#gr_22q13_3.REF.wilson.2008.1301">Wilson et al [2008]</a> reported two unrelated children with interstitial deletions of 22q13 proximal to, but not overlapping, <i>SHANK3</i>. The children had intellectual disability, severe language delay, hypotonia, and advanced height. The mother of one of the children who had the same <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a> as her <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> child had mild speech delay.</p><p>The potential contribution of genes other than <i>SHANK3</i> to the <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> of Phelan-McDermid syndrome has been suggested [<a class="bk_pop" href="#gr_22q13_3.REF.aldinger.2013.131">Aldinger et al 2013</a>, <a class="bk_pop" href="#gr_22q13_3.REF.sarasua.2014b.847">Sarasua et al 2014b</a>, <a class="bk_pop" href="#gr_22q13_3.REF.oberman.2015.105">Oberman et al 2015</a>, <a class="bk_pop" href="#gr_22q13_3.REF.tabet.2017.32">Tabet et al 2017</a>, <a class="bk_pop" href="#gr_22q13_3.REF.mitz.2018.293">Mitz et al 2018</a>]. The collective evidence suggests a potential role of genes more proximal than <i>SHANK3</i> in the observed clinical variability of this condition.</p><p><b>Gene structure.</b>
<i>SHANK3</i> encodes 22 canonic exons plus three alternatively spliced exons that are expressed only in tissue-specific <a class="def" href="/books/n/gene/glossary/def-item/isoforms/">isoforms</a>. The longest isoform produces a <a class="def" href="/books/n/gene/glossary/def-item/mrna/">mRNA</a> transcript of 7,031 nucleotides (<a href="https://www.ncbi.nlm.nih.gov/nuccore/NM_033517.1" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NM_033517.1</a>) and is expressed exclusively in brain and testes. Gene expression and function is regulated by both alternative <a class="def" href="/books/n/gene/glossary/def-item/splicing/">splicing</a> of three variable exons and <a class="def" href="/books/n/gene/glossary/def-item/methylation/">methylation</a> of four intragenic promoters, which control the transcription of tissue- and time-specific isoforms [<a class="bk_pop" href="#gr_22q13_3.REF.maunakea.2010.253">Maunakea et al 2010</a>].</p><p><b>Pathogenic variants.</b> Although the majority of Phelan-McDermid syndrome-associated variants are whole-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> deletions, a limited number of <a class="def" href="/books/n/gene/glossary/def-item/splice-site/">splice site</a>, <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a>, <a class="def" href="/books/n/gene/glossary/def-item/nonsense-variant/">nonsense</a>, and frameshift variants have been reported. Most individuals with <i>SHANK3</i> intragenic variants are described as having autism or intellectual disability [<a class="bk_pop" href="#gr_22q13_3.REF.boccuto.2013.310">Boccuto et al 2013</a>, <a class="bk_pop" href="#gr_22q13_3.REF.soorya.2013">Soorya et al 2013</a>, <a class="bk_pop" href="#gr_22q13_3.REF.leblond.2014.e1004580">Leblond et al 2014</a>, <a class="bk_pop" href="#gr_22q13_3.REF.oberman.2015.105">Oberman et al 2015</a>].</p><div id="gr_22q13_3.T.shank3_pathogenic_variants" class="table"><h3><span class="label">Table 7. </span></h3><div class="caption"><p><i>SHANK3</i> Pathogenic Variants Discussed in This <i>GeneReview</i></p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1198/table/gr_22q13_3.T.shank3_pathogenic_variants/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__gr_22q13_3.T.shank3_pathogenic_variants_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_gr_22q13_3.T.shank3_pathogenic_variants_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">DNA Nucleotide Change</th><th id="hd_h_gr_22q13_3.T.shank3_pathogenic_variants_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Predicted Protein Change</th><th id="hd_h_gr_22q13_3.T.shank3_pathogenic_variants_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Reference Sequences</th></tr></thead><tbody><tr><td headers="hd_h_gr_22q13_3.T.shank3_pathogenic_variants_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.3931delG</td><td headers="hd_h_gr_22q13_3.T.shank3_pathogenic_variants_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Glu1311fs</td><td headers="hd_h_gr_22q13_3.T.shank3_pathogenic_variants_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="https://www.ncbi.nlm.nih.gov/nuccore/NM_033517.1" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NM_033517<wbr style="display:inline-block"></wbr>​.1</a><br /><a href="https://www.ncbi.nlm.nih.gov/protein/NP_277052.1" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NP_277052<wbr style="display:inline-block"></wbr>​.1</a></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div><p class="no_margin">Variants listed in the table have been provided by the authors. <i>GeneReviews</i> staff have not independently verified the classification of variants.</p></div></dd><dt></dt><dd><div><p class="no_margin"><i>GeneReviews</i> follows the standard naming conventions of the Human Genome Variation Society (<a href="http://varnomen.hgvs.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">varnomen<wbr style="display:inline-block"></wbr>​.hgvs.org</a>). See <a href="/books/n/gene/app3/">Quick Reference</a> for an explanation of nomenclature.</p></div></dd></dl></div></div></div><p><b>Normal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b> The product of the main <a class="def" href="/books/n/gene/glossary/def-item/mrna/">mRNA</a> isoform of this gene, SH3 and multiple ankyrin repeat domains protein 3 (Shank3), is composed of 1,730 amino acids and belongs to a family of proteins that interact with receptors of the postsynaptic membrane. These multidomain proteins are important scaffolding molecules in the postsynaptic density (PSD) and function to receive and integrate synaptic signals and transduce them into postsynaptic cells. In addition to their role in the assembly of the PSD during synaptogenesis, the Shank proteins may play a role in synaptic plasticity and in the regulation of dendritic spine morphology [<a class="bk_pop" href="#gr_22q13_3.REF.boeckers.2002.903">Boeckers et al 2002</a>].</p><p><b>Abnormal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b> Loss-of-function variants or <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> rearrangements encompassing or disrupting <i>SHANK3</i> cause <a class="def" href="/books/n/gene/glossary/def-item/haploinsufficiency/">haploinsufficiency</a> of the gene, leading to destabilization of the PSD due to lack of Shank3 protein. In addition, pathogenic <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a> variants supposedly affecting the interaction of Shank3 with other PSD proteins result in a destabilizing effect.</p></div></div><div id="gr_22q13_3.References"><h2 id="_gr_22q13_3_References_">References</h2><div id="gr_22q13_3.Literature_Cited"><h3>Literature Cited</h3><ul class="simple-list"><li class="half_rhythm"><div class="bk_ref" id="gr_22q13_3.REF.aldinger.2013.131">Aldinger KA, Kogen J, Kimonis V, Fernandez B, Horn D, Klopocki E, Chung B, Toutain A, Weksberg R, Millen KJ, Barkovich AJ, Dobyns WB. Cerebellar and posterior fossa malformations in patients with autism-associated 22q13 terminal deletion. <span><span class="ref-journal">Am J Med Genet A. </span>2013;<span class="ref-vol">161A</span>:131–6.</span> [<a href="/pmc/articles/PMC3733662/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3733662</span></a>] [<a href="/pubmed/23225497" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23225497</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="gr_22q13_3.REF.anderlid.2002.439">Anderlid BM, Schoumans J, Anneren G, Tapia-Paez I, Dumanski J, Blennow E, Nordenskjold M. FISH-mapping of a 100-kb terminal 22q13 deletion. <span><span class="ref-journal">Hum Genet. </span>2002;<span class="ref-vol">110</span>:439–43.</span> [<a href="/pubmed/12073014" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12073014</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="gr_22q13_3.REF.bartsch.2010.2099">Bartsch O, Schneider E, Damatova N, Weis R, Tufano M, Iorio R, Ahmed A, Beyer V, Zechner U, Haaf T. Fulminant hepatic failure requiring liver transplantation in 22q13.3 deletion syndrome. <span><span class="ref-journal">Am J Med Genet A. </span>2010;<span class="ref-vol">152A</span>:2099–102.</span> [<a href="/pubmed/20635403" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 20635403</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="gr_22q13_3.REF.bisgaard.2009.175">Bisgaard A-M, Kirchoff M, Nielsen JE, Kibaek M, Lund A, Schwartz M, Christensen E. Chromosomal deletion unmasking a recessive disease: 22q13 deletion syndrome and metachromatic leukodystrophy. <span><span class="ref-journal">Clin Genet. </span>2009;<span class="ref-vol">75</span>:175–9.</span> [<a href="/pubmed/19054018" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19054018</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="gr_22q13_3.REF.boccuto.2013.310">Boccuto L, Lauri M, Sarasua SM, Skinner CD, Buccella D, Dwivedi A, Orteschi D, Collins JS, Zollino M, Visconti P, Dupont B, Tiziano D, Schroer RJ, Neri G, Stevenson RE, Gurrieri F, Schwartz CE. Prevalence of SHANK3 variants in patients with different subtypes of autism spectrum disorders. <span><span class="ref-journal">Eur J Hum Genet. </span>2013;<span class="ref-vol">21</span>:310–6.</span> [<a href="/pmc/articles/PMC3573207/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3573207</span></a>] [<a href="/pubmed/22892527" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22892527</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="gr_22q13_3.REF.boeckers.2002.903">Boeckers TM, Bockmann J, Kreutz MR, Gundelfinger ED. ProSAP/Shank prot. <span><span class="ref-journal">J Neurochem. </span>2002;<span class="ref-vol">81</span>:903–10.</span> [<a href="/pubmed/12065602" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12065602</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="gr_22q13_3.REF.bonaglia.2009.426">Bonaglia MC, Giorda R, Beri S, Bigoni S, Sensi A, Baroncini A, Capucci A, De Agostini C, Gwilliam R, Deloukas P, Dunham I, Zuffardi O. Mosaic 22q13 deletions: evidence for concurrent mosaic segmental isodisomy and gene conversion. <span><span class="ref-journal">Eur J Hum Genet. </span>2009;<span class="ref-vol">17</span>:426–33.</span> [<a href="/pmc/articles/PMC2682770/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2682770</span></a>] [<a href="/pubmed/18854866" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 18854866</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="gr_22q13_3.REF.bonaglia.2011.e1002173">Bonaglia MC, Giorda R, Beri S, De Agostini C, Novara F, Fichera M, Grillo L, Galesi O, Vetro A, Ciccone R, Bonati MT, Giglio S, Guerrini R, Osimani S, Marelli S, Zucca C, Grasso R, Borgatti R, Mani E, Motta C, Molteni M, Romano C, Donatella G, Reitano S, Baroncini A, Lapi E, Cecconi A, Guilia A, Patricelli MG, Pantaleoni C, D'Arrigo S, Riva D, Sciacca F, Bernadina BD, Zoccante L, Darra F, Termine C, Maserati E, Bigoni S, Priolo E, Bottani A, Gimelli S, Bena F, Brusco A, di Gregorio E, Bagnasco I, Guissani U, Nitsch L, Politi P, Martinez-Frias ML, Martinez-Fernandez ML, Martinez Guardia N, Bremer A, Anderlid B-M, Zuffardi O. Molecular mechanisms generating and stabilizing terminal 22q13 deletions in 44 subjects with Phelan/McDermid syndrome. <span><span class="ref-journal">PLoS Genet. </span>2011;<span class="ref-vol">7</span>:e1002173.</span> [<a href="/pmc/articles/PMC3136441/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3136441</span></a>] [<a href="/pubmed/21779178" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 21779178</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="gr_22q13_3.REF.bonaglia.2001.261">Bonaglia MC, Giorda R, Borgatti R, Felisari G, Gagliardi C, Selicorni A, Zuffardi O. Disruption of the ProSAP2 gene in a t(12;22)(q24.1;q13.3) is associated with the 22q13.3 deletion syndrome. <span><span class="ref-journal">Am J Hum Genet. </span>2001;<span class="ref-vol">69</span>:261–8.</span> [<a href="/pmc/articles/PMC1235301/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1235301</span></a>] [<a href="/pubmed/11431708" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11431708</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="gr_22q13_3.REF.bonaglia.2006.822">Bonaglia MC, Giorda R, Mani E, Aceti G, Anderlid BM, Baroncini A, Pramparo T, Zuffardi O. Identification of a recurrent breakpoint within the SHANK3 gene in the 22q13.3 deletion syndrome. <span><span class="ref-journal">J Med Genet. </span>2006;<span class="ref-vol">43</span>:822–8.</span> [<a href="/pmc/articles/PMC2563164/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2563164</span></a>] [<a href="/pubmed/16284256" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16284256</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="gr_22q13_3.REF.cho.2014.333">Cho EH, Park JB, Kim JK. Atypical teratoid rhabdoid brain tumor in an infant with ring chromosome 22. <span><span class="ref-journal">Korean J Pediatr. </span>2014;<span class="ref-vol">57</span>:333–6.</span> [<a href="/pmc/articles/PMC4127397/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4127397</span></a>] [<a href="/pubmed/25114695" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 25114695</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="gr_22q13_3.REF.cusmanoozog.2007.393">Cusmano-Ozog K, Manning MA, Hoyme HE. 22q13.3 deletion syndrome: a recognizable malformation syndrome associated with marked speech and language deletion. <span><span class="ref-journal">Am J Med Genet C Semin Med Genet. </span>2007;<span class="ref-vol">145C</span>:393–8.</span> [<a href="/pubmed/17926345" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17926345</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="gr_22q13_3.REF.dhar.2010.573">Dhar SU, del Guadio D, German JR, Peters SU, Ou Z, Bader PI, Berg JS, Blazo M, Brown CW, Graham BH, Grebe TA, Lalani S, Irons M, Sparagana S, Williams M, Philips JA III, Beaudet AL, Stankiewicz P, Patel A, Cheung SW, Sahoo T. 22q13.3 deletion syndrome: clinical and molecular analysis using array CGH. <span><span class="ref-journal">Am J Med Genet Part A. </span>2010;<span class="ref-vol">152A</span>:573–81.</span> [<a href="/pmc/articles/PMC3119894/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3119894</span></a>] [<a href="/pubmed/20186804" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 20186804</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="gr_22q13_3.REF.durand.2007.25">Durand CM, Betancur C, Boeckers TM, Bockmann J, Chaste P, Fauchereau F, Nygren G, Rastam M, Gillberg IC, Anckarsater H, Sponheim E, Goubran-Botros H, Delorme R, Chabane N, Mouren-Simeoni MC, de Mas P, Bieth E, Roge B, Heron D, Burglen L, Gillberg C, Leboyer M, Bourgeron T. Mutations in the gene encoding the synaptic scaffolding protein SHANK3 are associated with autism spectrum disorders. <span><span class="ref-journal">Nat Genet. </span>2007;<span class="ref-vol">39</span>:25–7.</span> [<a href="/pmc/articles/PMC2082049/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2082049</span></a>] [<a href="/pubmed/17173049" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17173049</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="gr_22q13_3.REF.egger.2017">Egger JIM, Verhoueven WMA, Groenendijk-Reijenga R, Kant SG (2017) Phelan-McDermid syndrome due to a SHANK3 mutation in an intellectually disabled adult male: successful treatment with lithium. Brit Med J Case Report pii:bcr-2017-220778. [<a href="/pmc/articles/PMC5652380/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC5652380</span></a>] [<a href="/pubmed/28963116" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 28963116</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="gr_22q13_3.REF.gauthier.2009.421">Gauthier J, Spiegelman D, Piton A, Lafreni&#x000e8;re RG, Laurent S, St-Onge J, Lapointe L, Hamdan FF, Cossette P, Mottron L, Fombonne E, Joober R, Marineau C, Drapeau P, Rouleau GA. Novel de novo SHANK3 mutation in autistic patients. <span><span class="ref-journal">Am J Med Genet B: Neuropsychiatr Genet. </span>2009;<span class="ref-vol">150B</span>:421–4.</span> [<a href="/pubmed/18615476" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 18615476</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="gr_22q13_3.REF.giza.2010.14805">Giza J, Urbanski MJ, Prestori F, Bandyopadhyay B, Yam A, Friedrich V, Kelley K, D'Angelo E, Goldfarb M. Behavioral and cerebellar transmission deficits in mice lacking the autism-linked gene islet brain-2. <span><span class="ref-journal">J Neurosci. </span>2010;<span class="ref-vol">30</span>:14805–16.</span> [<a href="/pmc/articles/PMC3200367/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3200367</span></a>] [<a href="/pubmed/21048139" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 21048139</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="gr_22q13_3.REF.guilmatre.2014.113">Guilmatre A, Huguet G, Delorme R, Bourgeron T. The emerging role of SHANK genes in neuropsychiatric disorders. <span><span class="ref-journal">Dev Neurobiol. </span>2014;<span class="ref-vol">74</span>:113–22.</span> [<a href="/pubmed/24124131" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 24124131</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="gr_22q13_3.REF.jeffries.2005.139">Jeffries AR, Curran S, Elmslie F, Sharma A, Wenger S, Hummel M, Powell J. Molecular and phenotypic characterization of ring chromosome 22. <span><span class="ref-journal">Am J Med Genet A. </span>2005;<span class="ref-vol">137</span>:139–47.</span> [<a href="/pubmed/16059935" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16059935</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="gr_22q13_3.REF.ko_.2009.978">Ko&#x000e7; A, Arisoy O, Pala E, Erdem M, Kaymak AO, Erkal O, Karaoguz MY. Prenatal diagnosis of mosaic ring 22 duplication/deletion with terminal 22q13 deletion due to abnormal first trimester screening and choroid plexus cyst detected on ultrasound. <span><span class="ref-journal">J Obstet Gynaecol Res. </span>2009;<span class="ref-vol">35</span>:978–82.</span> [<a href="/pubmed/20149051" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 20149051</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="gr_22q13_3.REF.kolevzon.2014a.39">Kolevzon A, Angarita B, Bush L, Wang AT, Frank Y, Yang A, Rapaport R, Saland J, Srivastava S, Farrell C, Edelmann LJ, Buxbaum JD. Phelan-McDermid syndrome: a review of the literature and practice parameters for medical assessment and monitoring. <span><span class="ref-journal">J Neurodev Disord. </span>2014a;<span class="ref-vol">6</span>:39–51.</span> [<a href="/pmc/articles/PMC4362650/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4362650</span></a>] [<a href="/pubmed/25784960" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 25784960</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="gr_22q13_3.REF.kolevzon.2014b.54">Kolevzon A, Bush L, Wang AT, Halpern D, Frank Y, Grodberg D, Rapaport R, Tavassoli T, Chaplin W, Soorya L, Buxbaum JD. A pilot controlled trial of insulin-like growth factor-1 in children with Phelan-McDermid syndrome. <span><span class="ref-journal">Mol Autism. </span>2014b;<span class="ref-vol">5</span>:54.</span> [<a href="/pmc/articles/PMC4326443/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4326443</span></a>] [<a href="/pubmed/25685306" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 25685306</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="gr_22q13_3.REF.leblond.2014.e1004580">Leblond CS, Nava C, Polge A, Gauthier J, Huguet G, Lumbroso S, Giuliano F, Stordeur C, Depienne C, Mouzat K, Pinto D, Howe J, Lemi&#x000e8;re N, Durand CM, Guibert J, Ey E, Toro R, Peyre H, Mathieu A, Amsellem F, Rastam M, Gillberg IC, Rappold GA, Holt R, Monaco AP, Maestrini E, Galan P, Heron D, Jacquette A, Afenjar A, Rastetter A, Brice A, Devillard F, Assouline B, Laffargue F, Lespinasse J, Chiesa J, Rivier F, Bonneau D, Regnault B, Zelenika D, Delepine M, Lathrop M, Sanlaville D, Schluth-Bolard C, Edery P, Perrin L, Tabet AC, Schmeisser MJ, Boeckers TM, Coleman M, Sato D, Szatmari P, Scherer SW, Rouleau GA, Betancur C, Leboyer M, Gillberg C, Delorme R, Bourgeron T. Meta-analysis of SHANK mutations in autism spectrum disorders: a gradient of severity in cognitive impairments. <span><span class="ref-journal">PLoS Genet. </span>2014;<span class="ref-vol">10</span>:e1004580.</span> [<a href="/pmc/articles/PMC4154644/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4154644</span></a>] [<a href="/pubmed/25188300" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 25188300</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="gr_22q13_3.REF.luciani.2003.690">Luciani JJ, de Mas P, Depetris D, Mignon-Ravix C, Bottani A, Prieur M, Jonveaux P, Philippe A, Bourrouillou G, de Martinville B, Delobel B, Vallee L, Croquette MF, Mattei MG. Telomeric 22q13 deletions resulting from rings, simple deletions, and translocations: cytogenetic, molecular, and clinical analyses of 32 new observations. <span><span class="ref-journal">J Med Genet. </span>2003;<span class="ref-vol">40</span>:690–6.</span> [<a href="/pmc/articles/PMC1735584/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1735584</span></a>] [<a href="/pubmed/12960216" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12960216</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="gr_22q13_3.REF.lyonswarren.2017.e205">Lyons-Warren AM, Cheung W, Holder JL Jr. Clinical reasoning: a common cause for Phelan-McDermid syndrome and neurofibromatosis type 1: one ring to bind them. <span><span class="ref-journal">Neurology. </span>2017;<span class="ref-vol">89</span>:e205–9.</span> [<a href="/pmc/articles/PMC5664307/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC5664307</span></a>] [<a href="/pubmed/29061681" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 29061681</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="gr_22q13_3.REF.maitz.2008.978">Maitz S, Gentilin B, Colli AM, Rizzuti T, Emilia Brandolisio E, Vetro A, Zuffardi O, Guerneri S, Lalatta F. Expanding the phenotype of 22q13.3 deletion: report of a case detected prenatally. <span><span class="ref-journal">Prenat Diagn. </span>2008;<span class="ref-vol">28</span>:978–80.</span> [<a href="/pubmed/18821718" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 18821718</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="gr_22q13_3.REF.maunakea.2010.253">Maunakea AK, Nagarajan RP, Bilenky M, Ballinger TJ, D'Souza C, Fouse SD, Johnson BE, Hong C, Nielsen C, Zhao Y, Turecki G, Delaney A, Varhol R, Thiessen N, Shchors K, Heine VM, Rowitch DH, Xing X, Fiore C, Schillebeeckx M, Jones SJ, Haussler D, Marra MA, Hirst M, Wang T, Costello JF. Conserved role of intragenic DNA methylation in regulating alternative promoters. <span><span class="ref-journal">Nature. </span>2010;<span class="ref-vol">466</span>:253–7.</span> [<a href="/pmc/articles/PMC3998662/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3998662</span></a>] [<a href="/pubmed/20613842" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 20613842</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="gr_22q13_3.REF.mcgaughran.2010.28">McGaughran J, Hadwen T, Clark R. Progressive edema leading to pleural effusions in a female with a ring chromosome 22 leading to a 22q13 deletion. <span><span class="ref-journal">Clin Dysmorph. </span>2010;<span class="ref-vol">19</span>:28–9.</span> [<a href="/pubmed/19940762" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19940762</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="gr_22q13_3.REF.mitz.2018.293">Mitz AR, Philyaw TJ, Boccuto L, Shcheglovitov A, Sarasua SM, Kaufmann WE, Thurm A. Identification of 22q13 genes most likely to contribute to Phelan McDermid syndrome. <span><span class="ref-journal">Eur J Hum Genet. </span>2018;<span class="ref-vol">26</span>:293–302.</span> [<a href="/pmc/articles/PMC5838980/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC5838980</span></a>] [<a href="/pubmed/29358616" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 29358616</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="gr_22q13_3.REF.oberman.2015.105">Oberman LM, Boccuto L, Cascio L, Sarasua S, Kaufmann WE. Autism spectrum disorder in Phelan-McDermid syndrome: initial characterization and genotype-phenotype correlations. <span><span class="ref-journal">Orphanet J Rare Dis. </span>2015;<span class="ref-vol">10</span>:105.</span> [<a href="/pmc/articles/PMC4549933/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4549933</span></a>] [<a href="/pubmed/26306707" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 26306707</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="gr_22q13_3.REF.phelan.2012.186">Phelan K, McDermid HE. The 22q13.3 deletion syndrome (Phelan-McDermid syndrome). <span><span class="ref-journal">Mol Syndromol. </span>2012;<span class="ref-vol">2</span>:186–201.</span> [<a href="/pmc/articles/PMC3366702/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3366702</span></a>] [<a href="/pubmed/22670140" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22670140</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="gr_22q13_3.REF.phelan.2001.1100">Phelan MC. Prenatal diagnosis of mosaicism for deletion 22q13.3. <span><span class="ref-journal">Prenat Diagn. </span>2001;<span class="ref-vol">21</span>:1100.</span> [<a href="/pubmed/11746171" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11746171</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="gr_22q13_3.REF.phelan.2010">Phelan MC, Stapleton GA, Rogers RC. Deletion 22q13 syndrome: Phelan-McDermid syndrome. In: Cassidy SB, Allanson JE, eds. <em>The Management of Genetic Syndromes</em>. 3 ed. Hoboken, NJ: John Wiley &#x00026; Sons; 2010:285-97.</div></li><li class="half_rhythm"><div class="bk_ref" id="gr_22q13_3.REF.philippe.2008.e376">Philippe A, Boddaert N, Vaivre-Douret L, Robel L, Danon-Boileau L, Malan V, de Blois M-C, Heron D, Colleaux L, Golse B, Zilbovicius M, Munnich A. Neurobehavioral profile and brain imaging study of the 22q13.3 deletion syndrome in childhood. <span><span class="ref-journal">Pediatrics. </span>2008;<span class="ref-vol">122</span>:e376–82.</span> [<a href="/pubmed/18625665" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 18625665</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="gr_22q13_3.REF.pinto.2014.677">Pinto D, Delaby E, Merico D, Barbosa M, Merikangas A, Klei L, Thiruvahindrapuram B, Xu X, Ziman R, Wang Z, Vorstman JA, Thompson A, Regan R, Pilorge M, Pellecchia G, Pagnamenta AT, Oliveira B, Marshall CR, Magalhaes TR, Lowe JK, Howe JL, Griswold AJ, Gilbert J, Duketis E, Dombroski BA, De Jonge MV, Cuccaro M, Crawford EL, Correia CT, Conroy J, Concei&#x000e7;&#x000e3;o IC, Chiocchetti AG, Casey JP, Cai G, Cabrol C, Bolshakova N, Bacchelli E, Anney R, Gallinger S, Cotterchio M, Casey G, Zwaigenbaum L, Wittemeyer K, Wing K, Wallace S, van Engeland H, Tryfon A, Thomson S, Soorya L, Rog&#x000e9; B, Roberts W, Poustka F, Mouga S, Minshew N, McInnes LA, McGrew SG, Lord C, Leboyer M, Le Couteur AS, Kolevzon A, Jim&#x000e9;nez Gonz&#x000e1;lez P, Jacob S, Holt R, Guter S, Green J, Green A, Gillberg C, Fernandez BA, Duque F, Delorme R, Dawson G, Chaste P, Caf&#x000e9; C, Brennan S, Bourgeron T, Bolton PF, B&#x000f6;lte S, Bernier R, Baird G, Bailey AJ, Anagnostou E, Almeida J, Wijsman EM, Vieland VJ, Vicente AM, Schellenberg GD, Pericak-Vance M, Paterson AD, Parr JR, Oliveira G, Nurnberger JI, Monaco AP, Maestrini E, Klauck SM, Hakonarson H, Haines JL, Geschwind DH, Freitag CM, Folstein SE, Ennis S, Coon H, Battaglia A, Szatmari P, Sutcliffe JS, Hallmayer J, Gill M, Cook EH, Buxbaum JD, Devlin B, Gallagher L, Betancur C, Scherer SW. Convergence of genes and cellular pathways dysregulated in autism spectrum disorders. <span><span class="ref-journal">Am J Hum Genet. </span>2014;<span class="ref-vol">94</span>:677–94.</span> [<a href="/pmc/articles/PMC4067558/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4067558</span></a>] [<a href="/pubmed/24768552" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 24768552</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="gr_22q13_3.REF.rahbari.2016.126">Rahbari R, Wuster A, Lindsay SJ, Hardwick RJ, Alexandrov LB, Turki SA, Dominiczak A, Morris A, Porteous D, Smith B, Stratton MR. UK10K Consortium, Hurles ME. Timing, rates and spectra of human germline mutation. <span><span class="ref-journal">Nat Genet. </span>2016;<span class="ref-vol">48</span>:126–33.</span> [<a href="/pmc/articles/PMC4731925/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4731925</span></a>] [<a href="/pubmed/26656846" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 26656846</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="gr_22q13_3.REF.reierson.2017.139">Reierson G, Bernstein J, Froehlich-Santino W, Urban A, Purmann C, Berquist S, Jordan J, O'Hara R, Hallmayer J. Characterizing regression in Phelan McDermid syndrome (22q13 deletion syndrome). <span><span class="ref-journal">J Psychiatr Res. </span>2017;<span class="ref-vol">91</span>:139–44.</span> [<a href="/pmc/articles/PMC5469716/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC5469716</span></a>] [<a href="/pubmed/28346892" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 28346892</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="gr_22q13_3.REF.riegel.2000.76">Riegel M, Baumer A, Wisser J, Acherman J, Schinzel A. Prenatal diagnosis of mosaicism for a del(22)(q13). <span><span class="ref-journal">Prenat Diagn. </span>2000;<span class="ref-vol">20</span>:76–9.</span> [<a href="/pubmed/10701858" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 10701858</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="gr_22q13_3.REF.rollins.2011.2324">Rollins JD, Sarasua SM, Phelan K, DuPont BR, Rogers CR, Collins JS. Growth in Phelan-McDermid syndrome. <span><span class="ref-journal">Am J Med Genet. </span>2011;<span class="ref-vol">155A</span>:2324–6.</span> [<a href="/pubmed/21834045" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 21834045</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="gr_22q13_3.REF.rubio.1997.1027">Rubio A. 4 year old girl with ring chromosome 22 and brain tumor (1977). <span><span class="ref-journal">Brain Pathol. </span>1997;<span class="ref-vol">7</span>:1027–8.</span> [<a href="/pubmed/9217983" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 9217983</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="gr_22q13_3.REF.sarasua.2014a.318">Sarasua SM, Dwivedi A, Boccuto L, Chen CF, Sharp JL, Rollins JD, Collins JS, Rogers RC, Phelan K, DuPont BR. 22q13.2q13.32 genomic regions associated with severity of speech delay, developmental delay, and physical features in Phelan-McDermid syndrome. <span><span class="ref-journal">Genet Med. </span>2014a;<span class="ref-vol">16</span>:318–28.</span> [<a href="/pubmed/24136618" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 24136618</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="gr_22q13_3.REF.sarasua.2011.761">Sarasua SM, Dwivedi A, Boccuto L, Rollins JD, Chen CF, Rogers RC, Phelan K, DuPont BR, Collins JS. Association between deletion size and important phenotypes expands the genomic region of interest in Phelan-McDermid syndrome (22q13 deletion syndrome). <span><span class="ref-journal">J Med Genet. </span>2011;<span class="ref-vol">48</span>:761–6.</span> [<a href="/pubmed/21984749" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 21984749</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="gr_22q13_3.REF.sarasua.2014b.847">Sarasua SM, Boccuto L, Sharp JL, Dwivedi A, Chen CF, Rollins JD, Rogers RC, Phelan K, DuPont BR. Clinical and genomic evaluation of 201 patients with Phelan-McDermid syndrome. <span><span class="ref-journal">Hum Genet. </span>2014b;<span class="ref-vol">133</span>:847–59.</span> [<a href="/pubmed/24481935" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 24481935</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="gr_22q13_3.REF.sathyamoorthi.2009.1067">Sathyamoorthi S, Morales J, Bermudez J, McBride L, Luquette M, McGoey R, Oates N, Hales S, Biegel JA, Lacassie Y. Array analysis and molecular studies of INI1 in an infant with deletion 22q13 (Phelan-McDermid syndrome) and atypical teratoid/rhabdoid tumor. <span><span class="ref-journal">Am J Med Genet A. </span>2009;<span class="ref-vol">149A</span>:1067–9.</span> [<a href="/pmc/articles/PMC3102295/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3102295</span></a>] [<a href="/pubmed/19334084" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19334084</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="gr_22q13_3.REF.serret.2015.107">Serret S, Thummler S, Dor E, Vesperini S, Santos A, Askenazy F. Lithium as a rescue therapy for regression and catatonia features in two SHANK3 patients with autism spectrum disorder: case reports. <span><span class="ref-journal">BMC Psychiatry. </span>2015;<span class="ref-vol">15</span>:107.</span> [<a href="/pmc/articles/PMC4428105/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4428105</span></a>] [<a href="/pubmed/25947967" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 25947967</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="gr_22q13_3.REF.soorya.2013">Soorya L, Kolevzon A, Zweifach J, Lim T, Dobry Y, Schwartz L, Frank Y, Wang AT, Cai G, Parkhomenko E, Halpern D, Grodberg D, Angarita B, Willner JP, Yang A, Canitano R, Chaplin W, Betancur C, Buxbaum JD (2013) Prospective investigation of autism and genotype-phenotype correlations in 22q13 deletion syndrome and SHANK3 deficiency. Mol Autism 11;4:18. [<a href="/pmc/articles/PMC3707861/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3707861</span></a>] [<a href="/pubmed/23758760" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23758760</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="gr_22q13_3.REF.tabet.2017.32">Tabet A-C, Rolland T, Ducloy M, Levy J, Buratti J, Mathieu A, Haye D, Perrin L, Dupont C, Passemard S, Capri Y, Verloes A, Drunat S, Keren B, Mignot C, Marey I, Jacquette A, Whalen A, Pipiras E, Benzacken B, Chantot-Bastaraud S, Afenjar A, Heron D, Le Caignec C, Beneteau C, Pichon O, Isidor B, David A, El Khattabi L, Kemeny S, Gouas L, Vago P, Mosca-Boidron A-L, Faivre L, Missirian C, Philip N, Sanlaville D, Edery P, Satre V, Coutton C, Devillard F, Dieterich K, Vuillaume M-L, Rooryck C, Lacombe D, Pinson L, Gatinois V, Puechberty J, Chiesa J, Lespinasse J, Dubourg C, Quelin C, Fradin M, Journel H, Toutain A, Martin D, Benmansour A, Leblond CS, Toro R, Amsellem F, Delorme R, Bourgeron T. A framework to identify contributing genes in patients with Phelan-McDermid syndrome. <span><span class="ref-journal">NPJ Genom Med. </span>2017;<span class="ref-vol">2</span>:32.</span> [<a href="/pmc/articles/PMC5677962/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC5677962</span></a>] [<a href="/pubmed/29263841" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 29263841</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="gr_22q13_3.REF.tabolacci.2005.127">Tabolacci E, Zollino M, Lecce R, Sangiorgi E, Gurrieri F, Leuzzi V, Opitz JM, Neri G. Two brothers with 22q13 deletion syndrome and features suggestive of the Clark-Baraitser syndrome. <span><span class="ref-journal">Clin Dysmorphol. </span>2005;<span class="ref-vol">14</span>:127–32.</span> [<a href="/pubmed/15930901" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15930901</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="gr_22q13_3.REF.terrone.2017.902">Terrone G, Vitiello G, Genesio R, D'Amico A, Imperati F, Ugga L, Giugliano R, Piluso G, Nitxhe L, Brunetti-Pierri N, Del Giudice E. A novel SHANK3 interstitial microdeletion in a family with intellectual disability and brain MRI abnormalities resembling Unidentified Bright Objects. <span><span class="ref-journal">Eur J Paediatr Neurol. </span>2017;<span class="ref-vol">21</span>:902–6.</span> [<a href="/pubmed/28754298" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 28754298</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="gr_22q13_3.REF.tucker.2014.792">Tucker T, Zahir F, Griffith M, Delaney A, Chai D, Tsang E, Lemyre E, Dobrzeniecka S, Marra M, Eydoux P, Langlois S, Hamdan FF, Michaud JL, Friedman JM. Single exon-resolution targeted chromosomal microarray analysis of known and candidate intellectual disability genes. <span><span class="ref-journal">Eur J Hum Genet. </span>2014;<span class="ref-vol">22</span>:792–800.</span> [<a href="/pmc/articles/PMC4023222/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4023222</span></a>] [<a href="/pubmed/24253858" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 24253858</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="gr_22q13_3.REF.tufano.2009.225">Tufano M, Della Corte D, Cirillo F, Spagnuolo MI, Candusso M, Melis D. Fulminant autoimmune hepatitis in a girl with 22q13 deletion syndrome: a previously unreported association. <span><span class="ref-journal">Eur J Pediatr. </span>2009;<span class="ref-vol">168</span>:225–7.</span> [<a href="/pubmed/18478261" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 18478261</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="gr_22q13_3.REF.wilson.2008.1301">Wilson HL, Crolla JA, Walker D, Artifoni L, Dallapiccola B, Takano T, Vasudevan P, Huang S, Maloney V, Yobb T, Quarrell O, McDermid HE. Interstitial 22q13 deletions: genes other than SHANK3 have major effects on cognitive and language development. <span><span class="ref-journal">Eur J Hum Genet. </span>2008;<span class="ref-vol">16</span>:1301–10.</span> [<a href="/pubmed/18523453" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 18523453</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="gr_22q13_3.REF.wilson.2003.575">Wilson HL, Wong AC, Shaw SR, Tse WY, Stapleton GA, Phelan MC, Hu S, Marshall J, McDermid HE. Molecular characterisation of the 22q13 deletion syndrome supports the role of haploinsufficiency of SHANK3/PROSAP2 in the major neurological symptoms. <span><span class="ref-journal">J Med Genet. </span>2003;<span class="ref-vol">40</span>:575–84.</span> [<a href="/pmc/articles/PMC1735560/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1735560</span></a>] [<a href="/pubmed/12920066" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12920066</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="gr_22q13_3.REF.wong.1997.113">Wong AC, Ning Y, Flint J, Clark K, Dumanski JP, Ledbetter DH, McDermid HE. Molecular characterization of a 130-kb terminal microdeletion at 22q in a child with mild mental retardation. <span><span class="ref-journal">Am J Hum Genet. </span>1997;<span class="ref-vol">60</span>:113–20.</span> [<a href="/pmc/articles/PMC1712560/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1712560</span></a>] [<a href="/pubmed/8981954" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 8981954</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="gr_22q13_3.REF.zirn.2012.82">Zirn B, Arning L, Bartels I, Shoukier M, Hoffjan G, Neubauer B, Hahn A. Ring chromosome 22 and neurofibromatosis type II: proof of a two-hit model for the loss of the NF2 gene in the development of meningioma. <span><span class="ref-journal">Clin Genet. </span>2012;<span class="ref-vol">81</span>:82–7.</span> [<a href="/pubmed/21175598" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 21175598</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="gr_22q13_3.REF.zwanenburg.2016.16">Zwanenburg RJ, Ruiter SAJ, van den Heuvel ER, Flapper BCT, Van Ravenswaaij-Arts MA. Developmental phenotype in Phelan-McDermid (22q13 deletion) syndrome: a systemic and prospective study in 34 children. <span><span class="ref-journal">J Neurodev Disord. </span>2016;<span class="ref-vol">8</span>:16.</span> [<a href="/pmc/articles/PMC4845478/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4845478</span></a>] [<a href="/pubmed/27118998" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 27118998</span></a>]</div></li></ul></div></div><div id="gr_22q13_3.Chapter_Notes"><h2 id="_gr_22q13_3_Chapter_Notes_">Chapter Notes</h2><div id="gr_22q13_3.Acknowledgments"><h3>Acknowledgments</h3><p>The authors gratefully acknowledge the members of the Phelan-McDermid Syndrome Foundation for their participation in research and for their generous sharing of information.</p></div><div id="gr_22q13_3.Revision_History"><h3>Revision History</h3><ul><li class="half_rhythm"><div>7 June 2018 (ha) Comprehensive update posted live</div></li><li class="half_rhythm"><div>25 August 2011 (me) Comprehensive update posted live</div></li><li class="half_rhythm"><div>25 October 2007 (me) Comprehensive update posted live</div></li><li class="half_rhythm"><div>11 May 2005 (me) Review posted live</div></li><li class="half_rhythm"><div>22 November 2004 (kp) Original submission</div></li></ul></div></div><div id="bk_toc_contnr"></div></div></div>
            <div class="post-content"><div><div class="half_rhythm"><a href="/books/about/copyright/">Copyright</a> © 1993-2019, University of Washington, Seattle. GeneReviews is
a registered trademark of the University of Washington, Seattle. All rights
reserved.<p class="small">GeneReviews® chapters are owned by the University of Washington. Permission is
hereby granted to reproduce, distribute, and translate copies of content materials for
noncommercial research purposes only, provided that (i) credit for source (<a href="http://www.genereviews.org/" ref="pagearea=meta&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">http://www.genereviews.org/</a>) and copyright (© 1993-2019 University of
Washington) are included with each copy; (ii) a link to the original material is provided
whenever the material is published elsewhere on the Web; and (iii) reproducers,
distributors, and/or translators comply with the <a href="/books/n/gene/GRcopyright_permiss/">GeneReviews® Copyright Notice and Usage
Disclaimer</a>. No further modifications are allowed. For clarity, excerpts
of GeneReviews chapters for use in lab reports and clinic notes are a permitted
use.</p><p class="small">For more information, see the <a href="/books/n/gene/GRcopyright_permiss/">GeneReviews® Copyright Notice and Usage
Disclaimer</a>.</p><p class="small">For questions regarding permissions or whether a specified use is allowed,
contact: <a href="mailto:dev@null" data-email="ude.wu@tssamda" class="oemail">ude.wu@tssamda</a>.</p></div><div class="small"><span class="label">Bookshelf ID: NBK1198</span><span class="label">PMID: <a href="/pubmed/20301377" title="PubMed record of this page" ref="pagearea=meta&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">20301377</a></span></div><div style="margin-top:2em" class="bk_noprnt"><a class="bk_cntns" href="/books/n/gene/">GeneReviews by Title</a><div class="pagination bk_noprnt"><a class="active page_link prev" href="/books/n/gene/pjs/" title="Previous page in this title">&lt; Prev</a><a class="active page_link next" href="/books/n/gene/pku/" title="Next page in this title">Next &gt;</a></div></div></div></div>
            
        </div>

        <!-- Custom content below content -->
        <div class="col4">
            
        </div>
        
        
        <!-- Book content -->
        
        <!-- Custom contetnt below bottom nav -->
        <div class="col5">
            
        </div>
    </div>

    <div id="rightcolumn" class="four_col col last">
        <!-- Custom content above discovery portlets -->
        <div class="col6">
            <div id="ncbi_share_book"><a href="#" class="ncbi_share" data-ncbi_share_config="popup:false,shorten:true" ref="id=NBK1198&amp;db=books">Share</a></div>

        </div>
        <div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Views</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="PDF_download" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="/books/NBK1198/?report=reader">PubReader</a></li><li><a href="/books/NBK1198/?report=printable">Print View</a></li><li><a data-jig="ncbidialog" href="#_ncbi_dlg_citbx_NBK1198" data-jigconfig="width:400,modal:true">Cite this Page</a><div id="_ncbi_dlg_citbx_NBK1198" style="display:none" title="Cite this Page"><div class="bk_tt">Phelan K, Rogers RC, Boccuto L. Phelan-McDermid Syndrome. 2005 May 11 [Updated 2018 Jun 7]. In: Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2019. <span class="bk_cite_avail"></span></div></div></li><li><a href="/books/NBK1198/pdf/Bookshelf_NBK1198.pdf">PDF version of this page</a> (563K)</li><li><a href="#" class="toggle-glossary-link" title="Enable/disable links to the glossary">Disable Glossary Links</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>In this GeneReview</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="page-toc" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="#gr_22q13_3.Summary" ref="log$=inpage&amp;link_id=inpage">Summary</a></li><li><a href="#gr_22q13_3.Diagnosis" ref="log$=inpage&amp;link_id=inpage">Diagnosis</a></li><li><a href="#gr_22q13_3.Clinical_Characteristics" ref="log$=inpage&amp;link_id=inpage">Clinical Characteristics</a></li><li><a href="#gr_22q13_3.Genetically_Related_Disorders" ref="log$=inpage&amp;link_id=inpage">Genetically Related Disorders</a></li><li><a href="#gr_22q13_3.Differential_Diagnosis" ref="log$=inpage&amp;link_id=inpage">Differential Diagnosis</a></li><li><a href="#gr_22q13_3.Management" ref="log$=inpage&amp;link_id=inpage">Management</a></li><li><a href="#gr_22q13_3.Genetic_Counseling" ref="log$=inpage&amp;link_id=inpage">Genetic Counseling</a></li><li><a href="#gr_22q13_3.Resources" ref="log$=inpage&amp;link_id=inpage">Resources</a></li><li><a href="#gr_22q13_3.Molecular_Genetics" ref="log$=inpage&amp;link_id=inpage">Molecular Genetics</a></li><li><a href="#gr_22q13_3.References" ref="log$=inpage&amp;link_id=inpage">References</a></li><li><a href="#gr_22q13_3.Chapter_Notes" ref="log$=inpage&amp;link_id=inpage">Chapter Notes</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>GeneReviews Links</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="source-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="/books/n/gene/advanced/"><i>GeneReviews</i> Advanced Search</a></li><li><a href="/books/n/gene/glossary/"><i>GeneReviews</i> Glossary</a></li><li><a href="/books/n/gene/resource_mats/">Resource Materials</a> <span class="bk_hlight1">NEW FEATURE</span></li><li><a href="/books/n/gene/updates/">New in <i>GeneReviews</i></a></li><li><a href="/books/n/gene/authors/">Author List</a></li><li><a href="/books/n/gene/prospective_authors/">For Current/Prospective Authors</a></li><li><a href="/books/n/gene/GRpersonnel/"><i>GeneReviews</i> Personnel</a></li><li><a href="/books/n/gene/howto_linkin/">Download/Link to <i>GeneReviews</i></a></li><li><a href="/books/n/gene/contact_us/">Contact Us</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Tests in GTR by Gene</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="document-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=85358[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">SHANK3</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Related information</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="discovery_db_links" id="Shutter"></a></div><div class="portlet_content"><ul><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=omim&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_omim&amp;IdsFromResult=1494360" ref="log$=recordlinks">OMIM</a><div class="brieflinkpop offscreen_noflow">Related OMIM records</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=pmc&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_pmc_refs&amp;IdsFromResult=1494360" ref="log$=recordlinks">PMC</a><div class="brieflinkpop offscreen_noflow">PubMed Central citations</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=pubmed&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_pubmed_refs&amp;IdsFromResult=1494360" ref="log$=recordlinks">PubMed</a><div class="brieflinkpop offscreen_noflow">Links to PubMed</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=gene&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_gene&amp;IdsFromResult=1494360" ref="log$=recordlinks">Gene</a><div class="brieflinkpop offscreen_noflow">Locus Links</div></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Similar articles in PubMed</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="PBooksDiscovery_RA" id="Shutter"></a></div><div class="portlet_content"><ul><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/18505557" ref="ordinalpos=1&amp;linkpos=1&amp;log$=relatedarticles&amp;logdbfrom=pubmed">Deletion 22q13.3 syndrome.</a><span class="source">[Orphanet J Rare Dis. 2008]</span><div class="brieflinkpop offscreen_noflow">Deletion 22q13.3 syndrome.<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Phelan MC. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">Orphanet J Rare Dis. 2008 May 27; 3:14. Epub 2008 May 27.</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/27741506" ref="ordinalpos=1&amp;linkpos=2&amp;log$=relatedarticles&amp;logdbfrom=pubmed">Clinical and genomic evaluation of a Chinese patient with a novel deletion associated with Phelan-McDermid syndrome.</a><span class="source">[Oncotarget. 2016]</span><div class="brieflinkpop offscreen_noflow">Clinical and genomic evaluation of a Chinese patient with a novel deletion associated with Phelan-McDermid syndrome.<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Lei D, Li S, Banerjee S, Zhang H, Li C, Hou S, Chen D, Yan H, Li H, Peng HH, et al. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">Oncotarget. 2016 Dec 6; 7(49):80327-80335. </em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/29719671" ref="ordinalpos=1&amp;linkpos=3&amp;log$=relatedarticles&amp;logdbfrom=pubmed">Delineation of the genetic and clinical spectrum of Phelan-McDermid syndrome caused by &lt;i&gt;SHANK3&lt;/i&gt; point mutations.</a><span class="source">[Mol Autism. 2018]</span><div class="brieflinkpop offscreen_noflow">Delineation of the genetic and clinical spectrum of Phelan-McDermid syndrome caused by &lt;i&gt;SHANK3&lt;/i&gt; point mutations.<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">De Rubeis S, Siper PM, Durkin A, Weissman J, Muratet F, Halpern D, Trelles MDP, Frank Y, Lozano R, Wang AT, et al. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">Mol Autism. 2018; 9:31. Epub 2018 Apr 27.</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/26350728" ref="ordinalpos=1&amp;linkpos=4&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Phelan McDermid Syndrome: From Genetic Discoveries to Animal Models and Treatment.</a><span class="source">[J Child Neurol. 2015]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Phelan McDermid Syndrome: From Genetic Discoveries to Animal Models and Treatment.<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Harony-Nicolas H, De Rubeis S, Kolevzon A, Buxbaum JD. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">J Child Neurol. 2015 Dec; 30(14):1861-70. Epub 2015 Sep 8.</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/25784960" ref="ordinalpos=1&amp;linkpos=5&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Phelan-McDermid syndrome: a review of the literature and practice parameters for medical assessment and monitoring.</a><span class="source">[J Neurodev Disord. 2014]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Phelan-McDermid syndrome: a review of the literature and practice parameters for medical assessment and monitoring.<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Kolevzon A, Angarita B, Bush L, Wang AT, Frank Y, Yang A, Rapaport R, Saland J, Srivastava S, Farrell C, et al. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">J Neurodev Disord. 2014; 6(1):39. Epub 2014 Oct 8.</em></div></div></li></ul><a class="seemore" href="/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed_reviews&amp;uid=20301377" ref="ordinalpos=1&amp;log$=relatedreviews_seeall&amp;logdbfrom=pubmed">See reviews...</a><a class="seemore" href="/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed&amp;uid=20301377" ref="ordinalpos=1&amp;log$=relatedarticles_seeall&amp;logdbfrom=pubmed">See all...</a></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Recent Activity</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="recent_activity" id="Shutter"></a></div><div class="portlet_content"><div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" id="HTDisplay" class=""><div class="action"><a href="javascript:historyDisplayState('ClearHT')">Clear</a><a href="javascript:historyDisplayState('HTOff')" class="HTOn">Turn Off</a><a href="javascript:historyDisplayState('HTOn')" class="HTOff">Turn On</a></div><ul id="activity"><li class="ra_rcd ralinkpopper two_line"><a class="htb ralinkpopperctrl" ref="log$=activity&amp;linkpos=1" href="/portal/utils/pageresolver.fcgi?recordid=5e04290edde08911699862f8">Phelan-McDermid Syndrome - GeneReviews®</a><div class="ralinkpop offscreen_noflow">Phelan-McDermid Syndrome - GeneReviews®<div class="brieflinkpopdesc"></div></div><div class="tertiary"></div></li></ul><p class="HTOn">Your browsing activity is empty.</p><p class="HTOff">Activity recording is turned off.</p><p id="turnOn" class="HTOff"><a href="javascript:historyDisplayState('HTOn')">Turn recording back on</a></p><a class="seemore" href="/sites/myncbi/recentactivity">See more...</a></div></div></div>
        
        <!-- Custom content below discovery portlets -->
        <div class="col7">
            
        </div>
    </div>
</div>

<!-- Custom content after all -->
<div class="col8">
    
</div>
<div class="col9">
    
</div>

<script type="text/javascript" src="/corehtml/pmc/js/jquery.scrollTo-1.4.2.js"></script>
<script type="text/javascript">
    (function($){
        $('.skiplink').each(function(i, item){
            var href = $($(item).attr('href'));
            href.attr('tabindex', '-1').addClass('skiptarget'); // ensure the target can receive focus
            $(item).on('click', function(event){
                event.preventDefault();
                $.scrollTo(href, 0, {
                    onAfter: function(){
                        href.focus();
                    }
                });
            });
        });
    })(jQuery);
</script>
                        </div>
                        <div class="bottom">
                            
                            <div id="NCBIFooter_dynamic">
    <a id="help-desk-link" class="help_desk" href="" target="_blank">Support Center</a>
    <a id="help-desk-link" class="help_desk" href="https://support.ncbi.nlm.nih.gov/ics/support/KBList.asp?Time=2019-12-25T22:29:18-05:00&amp;Snapshot=%2Fprojects%2Fbooks%2FPBooks@5.22&amp;Host=portal102&amp;ncbi_phid=CE89E932E041937100000000084003A8&amp;ncbi_session=CE89E932E04290D1_2112SID&amp;from=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fbooks%2FNBK1198%2F&amp;Db=pmc&amp;folderID=134&amp;Ncbi_App=bookshelf&amp;Page=literature&amp;style=classic&amp;deptID=28049" target="_blank">Support Center</a>
    
</div>

                            <div class="footer" id="footer">
    
    <div class="subfooter"> </div><script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/preloaderWidget.js"> </script>
    <div id="external-disclaimer" class="offscreen_noflow">
        External link. Please review our <a href="https://www.nlm.nih.gov/privacy.html">privacy policy</a>.
    </div>    
    <div id="ncbifooter" class="contact_info">      
        <div id="footer-contents-right">
            <div id="nlm_thumb_logo">
                <a href="https://www.nlm.nih.gov" title="NLM">NLM</a>
            </div>
            <div id="nih_thumb_logo">
                <a href="https://www.nih.gov" title="NIH">NIH</a>
            </div>
            <div id="hhs_thumb_logo">
                <a href="https://www.hhs.gov" title="DHHS">DHHS</a>
            </div>
            <div id="usagov_thumb_logo">
                <a href="https://www.usa.gov" title="USA.gov">USA.gov</a>
            </div>         
        </div>
        
        <div id="footer-contents-left">
            <p class="address vcard">
                <span class="url">
                    <a class="fn url newdomain" href="https://www.ncbi.nlm.nih.gov">National Center for
                        Biotechnology Information</a>,
                </span> <span class="org url newdomain"><a href="https://www.nlm.nih.gov/">U.S. National Library of Medicine</a></span>
                <span class="adr">
                    <span class="street-address">8600 Rockville Pike</span>, <span class="locality">Bethesda</span>
                    <span class="region">MD</span>, <span class="postal-code">20894</span>
                    <span class="country-name">USA</span>
                </span>
            </p>
            
            <a href="/home/about/policies.shtml">Policies and Guidelines</a> | <a href="/home/about/contact.shtml">Contact</a>
        </div>
    </div>
    <script type="text/javascript" src="/portal/portal3rc.fcgi/rlib/js/InstrumentOmnitureBaseJS/InstrumentNCBIConfigJS/InstrumentNCBIBaseJS/InstrumentPageStarterJS.js?v=1"> </script>    
    <script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/hfjs2.js"> </script>
</div>
                        </div>
                    </div>
                    <!--/.page-->
                </div>
                <!--/.wrap-->
            </div><!-- /.twelve_col -->
        </div>
        <!-- /.grid -->

        <span class="PAFAppResources"></span>
        
        <!-- BESelector tab -->
        
        
        
        <noscript><img alt="statistics" src="/stat?jsdisabled=true&amp;ncbi_db=books&amp;ncbi_pdid=book-part&amp;ncbi_acc=NBK1198&amp;ncbi_domain=gene&amp;ncbi_report=record&amp;ncbi_type=fulltext&amp;ncbi_objectid=&amp;ncbi_pcid=/NBK1198/&amp;ncbi_pagename=Phelan-McDermid Syndrome - GeneReviews® - NCBI Bookshelf&amp;ncbi_bookparttype=chapter&amp;ncbi_app=bookshelf" /></noscript>
        
        
        <!-- usually for JS scripts at page bottom -->
        <!--<component id="PageFixtures" label="styles"></component>-->
    

<!-- CE89E932E04290D1_2112SID /projects/books/PBooks@5.22 portal102 v4.1.r585844 Mon, May 06 2019 02:53:16 -->

<script type="text/javascript" src="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/js/3879255/4121861/3501987/4008961/3893018/3821238/4062932/4123007/4087685/4076480/3921943/3400083/3426610.js" snapshot="books"></script></body>
</html>